aldosterone has been researched along with Chronic Illness in 280 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we conducted an open-label and randomized trial to compare the effects of benidipine with those of amlodipine on blood pressure (BP), albuminuria and aldosterone concentration in hypertensive patients with mild-to-moderate stage chronic kidney disease (CKD)." | 9.15 | Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. ( Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M, 2011) |
| "73 m(2) and proteinuria with protein greater than 500 mg/g of creatinine on treatment with losartan, 100 mg/d, for longer than 6 months were screened in National Taiwan University Hospital." | 9.13 | Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. ( Chen, YM; Chiang, WC; Lin, SL; Tsai, TJ; Wu, KD, 2008) |
| " The present study compared the chronic effects of efonidipine and amlodipine on proteinuria in patients with chronic glomerulonephritis." | 9.12 | Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. ( Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M, 2007) |
| "To compare effects of various regimens of long-term monotherapy with quinapril (an ACE inhibitor) and valsartan (a type 1 angiotensin II receptors blocker) and combined therapy with these drugs on the activity of heurohormonal systems and 24-h heart rate variability (HRV) in patients with stable moderate chronic cardiac failure (CCF)." | 9.11 | [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o ( Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV, 2005) |
| " Forty-seven patients with mild stable chronic heart failure received candoxatril 400 mg/day, frusemide 40 mg/day or placebo for up to six weeks." | 9.09 | Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. ( Bostrøm, P; Christensen, CC; Parikka, H; Rykke, EO; Toivonen, L; Westheim, AS, 1999) |
| "In this group of patients with clinically stable moderate to severe chronic heart failure, only a marginal and statistically nonsignificant effect on clinical parameters was observed after 3 months of treatment with ibopamine." | 9.08 | Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. ( Girbes, AR; Kruik, J; Lie, KI; Szabó, BM; van der Burgh, PH; van Veldhuisen, DJ, 1996) |
| "The aim of this study was to evaluate the acute effects of transdermal nitroglycerin on the sympathetic and renin-angiotensin-aldosterone systems activity, in a group of patients with stable exercise induced angina pectoris." | 9.07 | Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity. ( Agabiti-Rosei, E; Beschi, M; Castellano, M; Cefis, M; Cerri, B; Muiesan, G; Muiesan, ML; Pollavini, G; Romanelli, G, 1992) |
| "We have previously shown that transdermal nitroglycerin may induce an increase in the activity of the adrenergic and the renin-angiotensin-aldosterone systems (SRAA) in patients with chronic stable angina pectoris (SA); when the activation of these systems is more pronounced, the antianginal effect of this drug seems to be reduced." | 9.07 | Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris. ( Agabiti-Rosei, E; Beschi, M; Boni, E; Castellano, M; Cefis, G; Cerri, B; Muiesan, ML; Pollavini, G; Porcellati, C; Verdecchia, P, 1993) |
| "Ten patients with severe chronic heart failure were given prazosin 5 mg and captopril 25 mg in random order on consecutive days." | 9.05 | Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects. ( Coxon, R; Sharpe, DN, 1982) |
| " More recently, the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study has provided firm support for the use of eplerenone (Inspra, Pfizer) in heart failure following acute myocardial infarction in addition to neurohormonal blockade with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta-blockers." | 8.82 | Eplerenone in the treatment of chronic heart failure. ( Krum, H; Liew, D, 2004) |
| "In patients with NYHA stage III or IV heart failure, addition of spironolactone to the treatment with conversion enzyme inhibitor, diuretic and/or digitalis leads to a reduction in morbidity and mortality, as demonstrated in the RALES study." | 8.82 | [Aldosterone and its antagonists in heart failure]. ( Badoual, T; Cachin, JC; Castaigne, A; Hittinger, L; Le Corvoisier, P; Lopes, ME; Merlet, P; Su, JB; Tabet, JY, 2003) |
| " We report our long-term single-practice experience in an unusual group of five patients with chronic hyperaldosteronism (HA, including three with glucocorticoid-remediable aldosteronism, GRA) treated with low-dose amiloride (a specific epithelial sodium channel [ENaC] blocker) 5-10 (mean 7) mg daily for 14-28 (mean 20) years." | 7.91 | Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism. ( Hong, M; Hussain, T; Izzo, JL; Osmond, PJ, 2019) |
| "The physiological mechanisms involved in isoproterenol (ISO)-induced chronic heart failure (CHF) are not fully understood." | 7.80 | Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide. ( Chen, LL; Hong, HS; Li, YH; Lin, XH; Zhu, XQ, 2014) |
| "We recently demonstrated that both lisinopril and candesartan, an angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor blocker, respectively, attenuate pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori (WBN/Kob) rats." | 7.73 | Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. ( Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T, 2005) |
| "By inhibiting prostaglandin synthesis, aspirin can interfere with both arterial functional and angiotensin-converting enzyme inhibitor (ACEI) properties and be deleterious in chronic heart failure (CHF)." | 7.72 | Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. ( Bergmann, JF; Caulin, C; Cohen-Solal, A; Habib, A; Jondeau, G; Kevorkian, JP; Knellwolf, AL; Lebret, M; Levy, B; Mahé, I; Meune, C; Mourad, JJ; Simoneau, G, 2003) |
| "The interaction between renal prostaglandins and atrial natriuretic factor (ANF) for the regulation of renal hemodynamic and excretory function was examined in conscious dogs with arteriovenous fistula and chronic compensated high-output heart failure (n = 6)." | 7.69 | Indomethacin attenuates the renal actions of atrial natriuretic factor in dogs with chronic heart failure. ( Freeman, RH; Habibullah, AA; Simmons, JC; Villarreal, D, 1997) |
| "Effects of guanfacine, a centrally acting antihypertensive, on blood pressure, heart rate, plasma renin activity, serum aldosterone, plasma norepinephrine, and renal function were evaluated in 16 patients with hypertension with biopsy-proved chronic glomerulonephritis." | 7.67 | Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis. ( Gomi, T; Ikeda, T; Nakayama, D; Sakurai, J; Yuhara, M, 1988) |
| "Atrial natriuretic peptide (ANP), angiotensin II (AII) and aldosterone (Aldo) in plasma were determined at supine rest in 16 normotensive and 9 hypertensive patients with chronic glomerulonephritis and in 18 control subjects (Study 1)." | 7.67 | Atrial natriuretic peptide, angiotensin II and aldosterone in plasma in chronic glomerulonephritis during basal conditions and during exercise. ( Danielsen, H; Pedersen, EB, 1988) |
| "This study was designed to examine the mechanisms that contribute to the chronic hypotensive effects of verapamil during angiotensin II-induced hypertension." | 7.67 | Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent. ( Lohmeier, TE; Montani, JP; Rushing, EL; Smith, MJ, 1989) |
| "The chronic reserve for the secretion of atrial natriuretic factor (ANF) was studied in conscious dogs with an arteriovenous (a-v) fistula, a model of high-output heart failure." | 7.67 | DOCA administration and atrial natriuretic factor in dogs with chronic heart failure. ( Brands, MW; Freeman, RH; Villarreal, D, 1989) |
| "To define the short-term haemodynamic, hormonal and electrolyte effects of enalapril in chronic heart failure, we administered it to nine patients." | 7.66 | Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure. ( Espiner, EA; Fitzpatrick, D; Ikram, H; Nicholls, MG, 1983) |
| "The angiotensin-converting enzyme inhibitor, captopril, was given to 19 patients with severe heart failure." | 7.66 | Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. ( Boomsma, F; Hugenholtz, PG; Laird-Meeter, K; Man in't veld, AJ; Schalekamp, MA; Simoons, ML; Wenting, GJ; Woittiez, AJ, 1983) |
| "The effects of indomethacin on plasma renin activity (PRA), plasma and urine aldosterone levels and on renal function were studied in 37 patients with chronic glomerulonephritis (GN)." | 7.66 | Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis. ( Androsova, SO; Kutyrina, IM; Tareyeva, IE; Warshavskii, VA, 1982) |
| "We studied the hemodynamic response to orally administered hydralazine (30 mg) and examined the changes in neurohumoral factors in 16 aged patients with chronic congestive heart failure." | 7.66 | Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure. ( Kuwajima, I; Matsushita, S; Murakami, M; Sakai, M; Ueda, K, 1983) |
| " The pharmacokinetic exposure of the LCZ696 analytes in patients with HF observed in this study is comparable to that observed in the pivotal Phase III study." | 6.82 | Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction. ( Albrecht, D; Averkov, O; Ayalasomayajula, S; Chandra, P; Jordaan, P; Kobalava, Z; Kotovskaya, Y; Langenickel, TH; Moiseev, V; Pal, P; Pavlikova, E; Prescott, MF; Rajman, I, 2016) |
| "Aliskiren appeared to suppress the RAAS as effectively as ramipril in the short term." | 6.73 | Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. ( Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A, 2007) |
| "Aldosterone levels were determined by solid-phase radioimmunoassay." | 6.70 | Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. ( Colombo, PC; Jorde, UP; Katz, SD; Latif, F; Le Jemtel, TH; Vittorio, T, 2002) |
| "In chronically treated heart failure patients with full angiotensin-converting enzyme-inhibition and diuretics, there is decreased compliance of the aorta and its major branches, which is inversely correlated with the aldosterone escape phenomenon." | 6.69 | Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. ( Clement, DL; Cohn, JN; De Buyzere, ML; Duprez, DA; Morgan, D; Rietzschel, ER; Taes, Y, 1998) |
| "Benazepril hydrochloride is a nonsulfhydryl, long-acting angiotensin-converting enzyme inhibitor that is orally effective." | 6.66 | A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure. ( Boland, MJ; Cinquegrani, MP; Insel, J; Mirvis, DM; Rubin, SA; Shanes, J; Whalen, JJ, 1989) |
| "Aldosterone is a mineralocorticoid hormone synthesized by the adrenal glands that has several regulatory functions to help the body maintain normal volume status and electrolyte balance." | 6.47 | Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure. ( Nappi, JM; Sieg, A, 2011) |
| "The neurohormonal model of congestive heart failure (CHF) has replaced the previously accepted hemodynamic model." | 6.43 | The role of aldosterone blockers in the management of chronic heart failure. ( Coca, SG; Perazella, MA, 2005) |
| "Aldosterone has been shown to have an acute arrhythmogenic effect as well as a detrimental effect on parasympathetic and baroreflex function." | 6.39 | Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. ( Struthers, AD, 1996) |
| "Aldosterone has been shown to have an acute arrhythmogenic effect as well as a potential detrimental effect on baroreflex function, a marker of prognosis in CHF." | 6.39 | Aldosterone escape during ACE inhibitor therapy in chronic heart failure. ( Struthers, AD, 1995) |
| "Aldosterone escape was defined as plasma levels of aldosterone above the normal range in our laboratory (> 0." | 5.31 | Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Caruso, B; Cicoira, M; Franceschini, L; Golia, G; Rossi, A; Zanolla, L; Zardini, P; Zeni, P, 2002) |
| " On the basis of the estimate of the dosing of digoxin these patients were divided into two groups: the first with therapeutic and the second with subtherapeutic concentrations of digoxin in serum." | 5.30 | The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure. ( Chmara, E; Jablecka, A; Korzeniowska, K, 1998) |
| "Primary aldosteronism is a potentially curable cause of hypertension; it occurs in about 1% of hypertensive patients." | 5.27 | 'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma. ( Almog, C; Burke, M; Papo, J; Stavorovsky, M, 1984) |
| " Therefore, during chronic captopril therapy of CHF, a reduction of diuretic dosage may be necessary to prevent orthostatic hypotension." | 5.26 | Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure. ( Cody, RJ; Franklin, KW; Laragh, JH, 1982) |
| "Hyperkalemia was not caused by an adrenal disorder or acidosis and could not be abolished by interventions enhancing K clearance; saline infusions, high doses of furosemide, cortisone, cortisol, long-acting synthetic ACTH and excessive doses of aldosterone." | 5.26 | Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies. ( Radó, JP; Szende, L; Szucs, L, 1976) |
| " To study the function and regulation of the aquaporin-2 water channel (AQP2) and the epithelial sodium channel (ENaC) in autosomal dominant polycystic kidney disease (ADPKD), we measured urinary excretion of AQP2 (u-AQP2), the β-subunit of ENaC (u-ENaC(β)), cAMP (u-cAMP), and prostaglandin E(2) (u-PGE(2)); free water clearance (C(H2O)); fractional sodium excretion (FE(Na)); and plasma vasopressin (p-AVP), renin (p-Renin), angiotensin II (p-ANG II), aldosterone (p-Aldo), and atrial and brain natriuretic peptide (p-ANP, p-BNP) in patients with ADPKD and healthy controls during 24-h urine collection and after hypertonic saline infusion during high sodium intake (HS; 300 mmol sodium/day) and low sodium intake (LS; 30 mmol sodium/day)." | 5.16 | Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion. ( Bech, JN; Graffe, CC; Lauridsen, TG; Pedersen, EB, 2012) |
| " In this study, we conducted an open-label and randomized trial to compare the effects of benidipine with those of amlodipine on blood pressure (BP), albuminuria and aldosterone concentration in hypertensive patients with mild-to-moderate stage chronic kidney disease (CKD)." | 5.15 | Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. ( Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M, 2011) |
| "73 m(2) and proteinuria with protein greater than 500 mg/g of creatinine on treatment with losartan, 100 mg/d, for longer than 6 months were screened in National Taiwan University Hospital." | 5.13 | Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. ( Chen, YM; Chiang, WC; Lin, SL; Tsai, TJ; Wu, KD, 2008) |
| " The present study compared the chronic effects of efonidipine and amlodipine on proteinuria in patients with chronic glomerulonephritis." | 5.12 | Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. ( Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M, 2007) |
| "To compare effects of various regimens of long-term monotherapy with quinapril (an ACE inhibitor) and valsartan (a type 1 angiotensin II receptors blocker) and combined therapy with these drugs on the activity of heurohormonal systems and 24-h heart rate variability (HRV) in patients with stable moderate chronic cardiac failure (CCF)." | 5.11 | [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o ( Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV, 2005) |
| " Forty-seven patients with mild stable chronic heart failure received candoxatril 400 mg/day, frusemide 40 mg/day or placebo for up to six weeks." | 5.09 | Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. ( Bostrøm, P; Christensen, CC; Parikka, H; Rykke, EO; Toivonen, L; Westheim, AS, 1999) |
| "In this group of patients with clinically stable moderate to severe chronic heart failure, only a marginal and statistically nonsignificant effect on clinical parameters was observed after 3 months of treatment with ibopamine." | 5.08 | Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. ( Girbes, AR; Kruik, J; Lie, KI; Szabó, BM; van der Burgh, PH; van Veldhuisen, DJ, 1996) |
| "We have previously shown that transdermal nitroglycerin may induce an increase in the activity of the adrenergic and the renin-angiotensin-aldosterone systems (SRAA) in patients with chronic stable angina pectoris (SA); when the activation of these systems is more pronounced, the antianginal effect of this drug seems to be reduced." | 5.07 | Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris. ( Agabiti-Rosei, E; Beschi, M; Boni, E; Castellano, M; Cefis, G; Cerri, B; Muiesan, ML; Pollavini, G; Porcellati, C; Verdecchia, P, 1993) |
| "The aim of this study was to evaluate the acute effects of transdermal nitroglycerin on the sympathetic and renin-angiotensin-aldosterone systems activity, in a group of patients with stable exercise induced angina pectoris." | 5.07 | Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity. ( Agabiti-Rosei, E; Beschi, M; Castellano, M; Cefis, M; Cerri, B; Muiesan, G; Muiesan, ML; Pollavini, G; Romanelli, G, 1992) |
| "Ten patients with severe chronic heart failure were given prazosin 5 mg and captopril 25 mg in random order on consecutive days." | 5.05 | Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects. ( Coxon, R; Sharpe, DN, 1982) |
| " More recently, the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study has provided firm support for the use of eplerenone (Inspra, Pfizer) in heart failure following acute myocardial infarction in addition to neurohormonal blockade with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta-blockers." | 4.82 | Eplerenone in the treatment of chronic heart failure. ( Krum, H; Liew, D, 2004) |
| "In patients with NYHA stage III or IV heart failure, addition of spironolactone to the treatment with conversion enzyme inhibitor, diuretic and/or digitalis leads to a reduction in morbidity and mortality, as demonstrated in the RALES study." | 4.82 | [Aldosterone and its antagonists in heart failure]. ( Badoual, T; Cachin, JC; Castaigne, A; Hittinger, L; Le Corvoisier, P; Lopes, ME; Merlet, P; Su, JB; Tabet, JY, 2003) |
| " We report our long-term single-practice experience in an unusual group of five patients with chronic hyperaldosteronism (HA, including three with glucocorticoid-remediable aldosteronism, GRA) treated with low-dose amiloride (a specific epithelial sodium channel [ENaC] blocker) 5-10 (mean 7) mg daily for 14-28 (mean 20) years." | 3.91 | Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism. ( Hong, M; Hussain, T; Izzo, JL; Osmond, PJ, 2019) |
| "The physiological mechanisms involved in isoproterenol (ISO)-induced chronic heart failure (CHF) are not fully understood." | 3.80 | Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide. ( Chen, LL; Hong, HS; Li, YH; Lin, XH; Zhu, XQ, 2014) |
| "Cortisol has been implicated in hypertension and lately reported to be regulated at the pre-receptor level by the 11betaHSD1 enzyme, which converts cortisone (E) to cortisol (F)." | 3.74 | [Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension]. ( Artigas, RA; Carvajal, CA; Fardella, CE; Morales, MA; Mosso, LM; Ortiz, E; Owen, GI, 2008) |
| "We recently demonstrated that both lisinopril and candesartan, an angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor blocker, respectively, attenuate pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori (WBN/Kob) rats." | 3.73 | Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. ( Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T, 2005) |
| "By inhibiting prostaglandin synthesis, aspirin can interfere with both arterial functional and angiotensin-converting enzyme inhibitor (ACEI) properties and be deleterious in chronic heart failure (CHF)." | 3.72 | Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. ( Bergmann, JF; Caulin, C; Cohen-Solal, A; Habib, A; Jondeau, G; Kevorkian, JP; Knellwolf, AL; Lebret, M; Levy, B; Mahé, I; Meune, C; Mourad, JJ; Simoneau, G, 2003) |
| "The interaction between renal prostaglandins and atrial natriuretic factor (ANF) for the regulation of renal hemodynamic and excretory function was examined in conscious dogs with arteriovenous fistula and chronic compensated high-output heart failure (n = 6)." | 3.69 | Indomethacin attenuates the renal actions of atrial natriuretic factor in dogs with chronic heart failure. ( Freeman, RH; Habibullah, AA; Simmons, JC; Villarreal, D, 1997) |
| "The effects of 1-year antihypertensive treatment with the diuretic fenquizone were evaluated in 16 patients with mild essential hypertension." | 3.68 | Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response. ( Ambrosioni, E; Borghi, C; Boschi, S; Costa, FV; Mussi, A, 1990) |
| "Long-term treatment with muzolimine in patients with essential hypertension has provided very interesting results." | 3.67 | Is the antihypertensive effect of muzolimine due to volume depletion? ( Andreucci, VE; Cofelice, E; Dal Canton, A; Oliva, O; Romano, G; Russo, D; Veniero, P, 1985) |
| "The chronic reserve for the secretion of atrial natriuretic factor (ANF) was studied in conscious dogs with an arteriovenous (a-v) fistula, a model of high-output heart failure." | 3.67 | DOCA administration and atrial natriuretic factor in dogs with chronic heart failure. ( Brands, MW; Freeman, RH; Villarreal, D, 1989) |
| "The aim of this paper was to study atrial natriuretic factor, plasma renin activity and antidiuretic hormone values during paroxysmal atrial arrhythmias with different ventricular rates before and after pharmacological cardioversion and during chronic atrial flutter-fibrillation." | 3.67 | [Atrial natriuretic factor in acute atrial hyperkinetic arrhythmia and chronic atrial fibrillo-flutter]. ( Bernardi, P; Capelli, M; Fontana, F; Spagnolo, N, 1989) |
| "This study was designed to examine the mechanisms that contribute to the chronic hypotensive effects of verapamil during angiotensin II-induced hypertension." | 3.67 | Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent. ( Lohmeier, TE; Montani, JP; Rushing, EL; Smith, MJ, 1989) |
| "Atrial natriuretic peptide (ANP), angiotensin II (AII) and aldosterone (Aldo) in plasma were determined at supine rest in 16 normotensive and 9 hypertensive patients with chronic glomerulonephritis and in 18 control subjects (Study 1)." | 3.67 | Atrial natriuretic peptide, angiotensin II and aldosterone in plasma in chronic glomerulonephritis during basal conditions and during exercise. ( Danielsen, H; Pedersen, EB, 1988) |
| "Atrial natriuretic peptide (ANP), angiotensin II (AII), aldosterone (Aldo), arginine vasopressin (AVP) in plasma, urinary excretion of prostaglandin E2 (PGE2) and urinary sodium excretion rate (UNaV) were determined in 11 normotensive patients with chronic glomerulonephritis and a normal glomerular filtration rate (GFR) and in 14 healthy control subjects before, during and after intravenous infusion of a 2." | 3.67 | Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis. ( Danielsen, H; Pedersen, EB; Sørensen, SS, 1988) |
| "Effects of guanfacine, a centrally acting antihypertensive, on blood pressure, heart rate, plasma renin activity, serum aldosterone, plasma norepinephrine, and renal function were evaluated in 16 patients with hypertension with biopsy-proved chronic glomerulonephritis." | 3.67 | Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis. ( Gomi, T; Ikeda, T; Nakayama, D; Sakurai, J; Yuhara, M, 1988) |
| "To define the short-term haemodynamic, hormonal and electrolyte effects of enalapril in chronic heart failure, we administered it to nine patients." | 3.66 | Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure. ( Espiner, EA; Fitzpatrick, D; Ikram, H; Nicholls, MG, 1983) |
| "The effects of indomethacin on plasma renin activity (PRA), plasma and urine aldosterone levels and on renal function were studied in 37 patients with chronic glomerulonephritis (GN)." | 3.66 | Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis. ( Androsova, SO; Kutyrina, IM; Tareyeva, IE; Warshavskii, VA, 1982) |
| "We studied the hemodynamic response to orally administered hydralazine (30 mg) and examined the changes in neurohumoral factors in 16 aged patients with chronic congestive heart failure." | 3.66 | Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure. ( Kuwajima, I; Matsushita, S; Murakami, M; Sakai, M; Ueda, K, 1983) |
| "The angiotensin-converting enzyme inhibitor, captopril, was given to 19 patients with severe heart failure." | 3.66 | Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. ( Boomsma, F; Hugenholtz, PG; Laird-Meeter, K; Man in't veld, AJ; Schalekamp, MA; Simoons, ML; Wenting, GJ; Woittiez, AJ, 1983) |
| "To assess relationships between plasma bradykinin and the individual elements of the renin-angiotensin-aldosterone system 11 normal subjects and five subjects with adrenal insufficiency were studied on an intake of 200 mEq sodium/100 mEq potassium." | 3.65 | Relationship between aldosterone and bradykinin. ( Dluhy, RG; Hollenberg, NK; Mersey, JH; Williams, GH, 1977) |
| "Chronic hypertension has been produced in mongrel dogs by the long-term oral administration of metyrapone (100 mg/kg per day)." | 3.65 | Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs. ( Bravo, EL; Dustan, HP; Tarazi, RC, 1977) |
| "Superimposed preeclampsia complicates about 20% of pregnancies in women with chronic hypertension and is associated with increased maternal and perinatal morbidity compared with preeclampsia alone." | 2.82 | Chronic hypertension and superimposed preeclampsia: screening and diagnosis. ( Kametas, NA; Nicolaides, KH; Nzelu, D, 2022) |
| " The pharmacokinetic exposure of the LCZ696 analytes in patients with HF observed in this study is comparable to that observed in the pivotal Phase III study." | 2.82 | Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction. ( Albrecht, D; Averkov, O; Ayalasomayajula, S; Chandra, P; Jordaan, P; Kobalava, Z; Kotovskaya, Y; Langenickel, TH; Moiseev, V; Pal, P; Pavlikova, E; Prescott, MF; Rajman, I, 2016) |
| "Aliskiren appeared to suppress the RAAS as effectively as ramipril in the short term." | 2.73 | Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. ( Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A, 2007) |
| "Aldosterone has been implicated in the progression of heart failure." | 2.71 | Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial. ( Anand, IS; Chiang, YT; Cohn, JN; Glazer, R; Latini, R; Masson, S, 2003) |
| "Aldosterone levels were determined by solid-phase radioimmunoassay." | 2.70 | Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. ( Colombo, PC; Jorde, UP; Katz, SD; Latif, F; Le Jemtel, TH; Vittorio, T, 2002) |
| "In chronically treated heart failure patients with full angiotensin-converting enzyme-inhibition and diuretics, there is decreased compliance of the aorta and its major branches, which is inversely correlated with the aldosterone escape phenomenon." | 2.69 | Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. ( Clement, DL; Cohn, JN; De Buyzere, ML; Duprez, DA; Morgan, D; Rietzschel, ER; Taes, Y, 1998) |
| "Benazepril hydrochloride is a nonsulfhydryl, long-acting angiotensin-converting enzyme inhibitor that is orally effective." | 2.66 | A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure. ( Boland, MJ; Cinquegrani, MP; Insel, J; Mirvis, DM; Rubin, SA; Shanes, J; Whalen, JJ, 1989) |
| " The efficacy of MMF as an immunosuppressant and long-term safety in cats of this dosage regimen is unknown." | 2.61 | ( Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019) |
| "In the setting of primary aldosteronism, renal and faecal calcium loss triggers increased PTH secretion which in turn aggravates aldosterone secretion and CV damage." | 2.48 | Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. ( Drechsler, C; Fahrleitner-Pammer, A; Horina, JH; Kienreich, K; März, W; Ofner, M; Pieber, TR; Pieske, B; Pilz, S; Ritz, E; Tomaschitz, A, 2012) |
| "Aldosterone is a mineralocorticoid hormone synthesized by the adrenal glands that has several regulatory functions to help the body maintain normal volume status and electrolyte balance." | 2.47 | Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure. ( Nappi, JM; Sieg, A, 2011) |
| "The neurohormonal model of congestive heart failure (CHF) has replaced the previously accepted hemodynamic model." | 2.43 | The role of aldosterone blockers in the management of chronic heart failure. ( Coca, SG; Perazella, MA, 2005) |
| "Aldosterone has been shown to have an acute arrhythmogenic effect as well as a potential detrimental effect on baroreflex function, a marker of prognosis in CHF." | 2.39 | Aldosterone escape during ACE inhibitor therapy in chronic heart failure. ( Struthers, AD, 1995) |
| "Aldosterone has been shown to have an acute arrhythmogenic effect as well as a detrimental effect on parasympathetic and baroreflex function." | 2.39 | Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. ( Struthers, AD, 1996) |
| "To evaluate the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function." | 1.35 | Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. ( Cerasola, G; Cottone, S; Cusimano, P; Mulè, G; Nardi, E; Palermo, A, 2009) |
| "Substance P was found to be increased in chronic liver disease patients; this increase was accompanied by an increase of aldosterone and plasma rennin activity." | 1.33 | Study of substance P, renin and aldosterone in chronic liver disease in Egyptian children. ( El-Raziky, M; El-Raziky, MS; Gohar, N, 2005) |
| "Patients with liver cirrhosis and chronic heart failure (CHF) have a reduced capacity to excrete water." | 1.32 | Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. ( Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS, 2003) |
| "Aldosterone escape was defined as plasma levels of aldosterone above the normal range in our laboratory (> 0." | 1.31 | Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Caruso, B; Cicoira, M; Franceschini, L; Golia, G; Rossi, A; Zanolla, L; Zardini, P; Zeni, P, 2002) |
| "Aldosterone treatment had no visible effect." | 1.30 | Ultrastructure of the endolymphatic sac in two-phase endolymphatic hydrops in the guinea pig. ( Albers, FW; Blaauw, EH; Dunnebier, EA; Segenhout, JM; Verheul, J; Wit, HP, 1999) |
| " On the basis of the estimate of the dosing of digoxin these patients were divided into two groups: the first with therapeutic and the second with subtherapeutic concentrations of digoxin in serum." | 1.30 | The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure. ( Chmara, E; Jablecka, A; Korzeniowska, K, 1998) |
| "The association of hypokalemia, aldosteronism, and renal cysts was also supported by the finding of multiple medullary cysts in two patients with primary renal potassium wasting." | 1.28 | Association of hypokalemia, aldosteronism, and renal cysts. ( Hattery, RR; Offord, KP; Torres, VE; Young, WF, 1990) |
| "Plasma ADH, PA and PRA in patients with respiratory failure (RF) were studied." | 1.28 | [ADH (anti-diuretic hormone), aldosterone (PA) and renin activity (PRA) in patients with respiratory failure]. ( Hashimoto, T; Nakamata, M; Tsukioka, K, 1989) |
| "In patients with MPGN, the levels of total renin (TR) and inactive renin (IR) were significantly higher than in those suffering from MSPGN." | 1.28 | [The morphofunctional parallels in arterial hypertension in patients with chronic glomerulonephritis]. ( Degtereva, OA; Gadaev, A; Kaiukov, IG; Kotovoĭ, IuO; Kucher, AG; Riabov, SI, 1992) |
| "Primary aldosteronism is a potentially curable cause of hypertension; it occurs in about 1% of hypertensive patients." | 1.27 | 'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma. ( Almog, C; Burke, M; Papo, J; Stavorovsky, M, 1984) |
| " These results demonstrate that chronic administration of ANF not only reduces blood pressure and PRA in 2-K, 1-C hypertensive rats but also plasma and urinary aldosterone." | 1.27 | Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats. ( Cantin, M; Garcia, R; Gutkowska, J; Thibault, G, 1986) |
| "To elucidate the effect of bed rest used as an adjunct to increased diuretic treatment, twelve patients with chronic congestive heart failure (CHF) had a 50% increase in loop diuretic dosage and were allocated to either continuous bed rest or bed rest during nights only." | 1.27 | Bed rest and increased diuretic treatment in chronic congestive heart failure. ( Abildgaard, U; Aldershvile, J; Christensen, NJ; Falk, J; Giese, J; Hammer, M; Henriksen, JH; Ring-Larsen, H, 1985) |
| " Therefore, during chronic captopril therapy of CHF, a reduction of diuretic dosage may be necessary to prevent orthostatic hypotension." | 1.26 | Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure. ( Cody, RJ; Franklin, KW; Laragh, JH, 1982) |
| "Hyperkalemia was not caused by an adrenal disorder or acidosis and could not be abolished by interventions enhancing K clearance; saline infusions, high doses of furosemide, cortisone, cortisol, long-acting synthetic ACTH and excessive doses of aldosterone." | 1.26 | Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies. ( Radó, JP; Szende, L; Szucs, L, 1976) |
| "Propranolol was given to 10 hypertensive patients with CGN and hypotensive effect on renal function was observed." | 1.25 | Therapy and prognosis of hypertension in chronic nephritis. ( Kajiwara, N, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 134 (47.86) | 18.7374 |
| 1990's | 45 (16.07) | 18.2507 |
| 2000's | 62 (22.14) | 29.6817 |
| 2010's | 37 (13.21) | 24.3611 |
| 2020's | 2 (0.71) | 2.80 |
| Authors | Studies |
|---|---|
| Kametas, NA | 1 |
| Nzelu, D | 1 |
| Nicolaides, KH | 1 |
| Berkowicz, P | 1 |
| Totoń-Żurańska, J | 1 |
| Kwiatkowski, G | 1 |
| Jasztal, A | 1 |
| Csípő, T | 1 |
| Kus, K | 1 |
| Tyrankiewicz, U | 1 |
| Orzyłowska, A | 1 |
| Wołkow, P | 1 |
| Tóth, A | 1 |
| Chlopicki, S | 1 |
| Canonica, J | 1 |
| Mehanna, C | 1 |
| Bonnard, B | 1 |
| Jonet, L | 1 |
| Gelize, E | 1 |
| Jais, JP | 1 |
| Jaisser, F | 2 |
| Zhao, M | 1 |
| Behar-Cohen, F | 1 |
| Bobenko, AI | 1 |
| Heller, S | 1 |
| Schmitt, N | 1 |
| Cherdtrakulkiat, R | 1 |
| Lawung, R | 1 |
| Nabu, S | 1 |
| Tantimavanich, S | 1 |
| Sinthupoom, N | 1 |
| Prachayasittikul, S | 1 |
| Prachayasittikul, V | 1 |
| Zhang, B | 1 |
| Wu, C | 1 |
| Zhang, Z | 2 |
| Yan, K | 1 |
| Li, C | 2 |
| Li, Y | 4 |
| Li, L | 3 |
| Zheng, C | 1 |
| Xiao, Y | 1 |
| He, D | 1 |
| Zhao, F | 1 |
| Su, JF | 1 |
| Lun, SM | 1 |
| Hou, YJ | 1 |
| Duan, LJ | 1 |
| Wang, NC | 1 |
| Shen, FF | 1 |
| Zhang, YW | 1 |
| Gao, ZW | 1 |
| Li, J | 6 |
| Du, XJ | 1 |
| Zhou, FY | 1 |
| Yin, Z | 1 |
| Zhu, J | 2 |
| Yan, D | 1 |
| Lou, H | 1 |
| Yu, H | 1 |
| Feng, C | 1 |
| Wang, Z | 1 |
| Wang, Y | 4 |
| Hu, X | 1 |
| Li, Z | 2 |
| Shen, Y | 1 |
| Hu, D | 1 |
| Chen, H | 1 |
| Wu, X | 1 |
| Duan, Y | 1 |
| Zhi, D | 1 |
| Zou, M | 2 |
| Zhao, Z | 1 |
| Zhang, X | 2 |
| Yang, X | 2 |
| Zhang, J | 2 |
| Wang, H | 1 |
| Popović, KJ | 1 |
| Popović, DJ | 1 |
| Miljković, D | 1 |
| Lalošević, D | 1 |
| Čapo, I | 1 |
| Popović, JK | 1 |
| Liu, M | 1 |
| Song, H | 2 |
| Xing, Z | 1 |
| Lu, G | 1 |
| Chen, D | 1 |
| Valentini, AM | 1 |
| Di Pinto, F | 1 |
| Coletta, S | 1 |
| Guerra, V | 1 |
| Armentano, R | 1 |
| Caruso, ML | 1 |
| Gong, J | 1 |
| Wang, N | 1 |
| Bian, L | 1 |
| Wang, M | 1 |
| Ye, M | 1 |
| Wen, N | 1 |
| Fu, M | 1 |
| Fan, W | 1 |
| Meng, Y | 1 |
| Dong, G | 1 |
| Lin, XH | 2 |
| Liu, HH | 1 |
| Gao, DM | 1 |
| Cui, JF | 1 |
| Ren, ZG | 1 |
| Chen, RX | 1 |
| Önal, B | 1 |
| Özen, D | 1 |
| Demir, B | 1 |
| Akkan, AG | 1 |
| Özyazgan, S | 1 |
| Payette, G | 1 |
| Geoffroy, V | 1 |
| Martineau, C | 1 |
| Villemur, R | 1 |
| Jameel, T | 1 |
| Baig, M | 1 |
| Gazzaz, ZJ | 1 |
| Tashkandi, JM | 1 |
| Al Alhareth, NS | 1 |
| Khan, SA | 1 |
| Butt, NS | 1 |
| Wang, J | 2 |
| Geng, Y | 1 |
| Zhang, Y | 4 |
| Wang, X | 2 |
| Liu, J | 3 |
| Basit, A | 1 |
| Miao, T | 1 |
| Liu, W | 1 |
| Jiang, W | 1 |
| Yu, ZY | 1 |
| Wu, L | 2 |
| Qu, B | 1 |
| Sun, JX | 1 |
| Cai, AL | 1 |
| Xie, LM | 1 |
| Groeneveld, J | 1 |
| Ho, SL | 1 |
| Mackensen, A | 1 |
| Mohtadi, M | 1 |
| Laepple, T | 1 |
| Genovesi, S | 1 |
| Nava, E | 1 |
| Bartolucci, C | 1 |
| Severi, S | 1 |
| Vincenti, A | 1 |
| Contaldo, G | 1 |
| Bigatti, G | 1 |
| Ciurlino, D | 1 |
| Bertoli, SV | 1 |
| Slovak, JE | 1 |
| Hwang, JK | 1 |
| Rivera, SM | 1 |
| Villarino, NF | 1 |
| Li, S | 2 |
| Cao, G | 1 |
| Ling, M | 1 |
| Ji, J | 1 |
| Zhao, D | 1 |
| Sha, Y | 1 |
| Gao, X | 1 |
| Liang, C | 2 |
| Guo, Q | 1 |
| Zhou, C | 1 |
| Ma, Z | 1 |
| Xu, J | 1 |
| Wang, C | 1 |
| Zhao, W | 2 |
| Xia, X | 1 |
| Jiang, Y | 1 |
| Peng, J | 1 |
| Jia, Z | 1 |
| Li, F | 1 |
| Chen, X | 2 |
| Mo, J | 1 |
| Zhang, S | 2 |
| Li, X | 1 |
| Huang, T | 1 |
| Zhu, Q | 1 |
| Wang, S | 1 |
| Ge, RS | 1 |
| Fortunato, G | 1 |
| Lin, J | 2 |
| Agarwal, PK | 1 |
| Kohen, A | 1 |
| Singh, P | 1 |
| Cheatum, CM | 1 |
| Zhu, D | 1 |
| Hayman, A | 1 |
| Kebede, B | 1 |
| Stewart, I | 1 |
| Chen, G | 1 |
| Frew, R | 1 |
| Guo, X | 1 |
| Gong, Q | 1 |
| Borowiec, J | 1 |
| Han, S | 1 |
| Zhang, M | 1 |
| Willis, M | 1 |
| Kreouzis, T | 1 |
| Yu, K | 1 |
| Chirvony, VS | 1 |
| Sekerbayev, KS | 1 |
| Pérez-Del-Rey, D | 1 |
| Martínez-Pastor, JP | 1 |
| Palazon, F | 1 |
| Boix, PP | 1 |
| Taurbayev, TI | 1 |
| Sessolo, M | 1 |
| Bolink, HJ | 1 |
| Lu, M | 1 |
| Lan, Y | 1 |
| Xiao, J | 1 |
| Song, M | 1 |
| Chen, C | 1 |
| Huang, Q | 1 |
| Cao, Y | 1 |
| Ho, CT | 1 |
| Qi, B | 1 |
| Wang, Q | 2 |
| Zhang, W | 1 |
| Fang, L | 1 |
| Xie, CL | 1 |
| Chen, R | 1 |
| Yang, S | 1 |
| Xia, JM | 1 |
| Zhang, GY | 1 |
| Chen, CH | 1 |
| Yang, XW | 1 |
| Domenech-Ximenos, B | 1 |
| Garza, MS | 1 |
| Prat-González, S | 1 |
| Sepúlveda-Martínez, Á | 1 |
| Crispi, F | 1 |
| Perea, RJ | 1 |
| Garcia-Alvarez, A | 1 |
| Sitges, M | 1 |
| Kalumpha, M | 1 |
| Guyo, U | 1 |
| Zinyama, NP | 1 |
| Vakira, FM | 1 |
| Nyamunda, BC | 1 |
| Varga, M | 1 |
| Drácz, L | 1 |
| Kolbenheyer, E | 1 |
| Varga, F | 1 |
| Patai, ÁV | 1 |
| Solymosi, N | 1 |
| Patai, Á | 1 |
| Kiss, J | 1 |
| Gaál, V | 1 |
| Nyul, Z | 1 |
| Mosdósi, B | 1 |
| Valdez, M | 1 |
| Moosavi, L | 1 |
| Heidari, A | 1 |
| Novakovic-Agopian, T | 1 |
| Kornblith, E | 1 |
| Abrams, G | 1 |
| McQuaid, JR | 1 |
| Posecion, L | 1 |
| Burciaga, J | 1 |
| D'Esposito, M | 1 |
| Chen, AJW | 1 |
| Samy El Gendy, NM | 1 |
| Wesolowska, P | 1 |
| Georg, D | 1 |
| Lechner, W | 1 |
| Kazantsev, P | 1 |
| Bokulic, T | 1 |
| Tedgren, AC | 1 |
| Adolfsson, E | 1 |
| Campos, AM | 1 |
| Alves, VGL | 1 |
| Suming, L | 1 |
| Hao, W | 1 |
| Ekendahl, D | 1 |
| Koniarova, I | 1 |
| Bulski, W | 1 |
| Chelminski, K | 1 |
| Samper, JLA | 1 |
| Vinatha, SP | 1 |
| Rakshit, S | 1 |
| Siri, S | 1 |
| Tomsejm, M | 1 |
| Tenhunen, M | 1 |
| Povall, J | 1 |
| Kry, SF | 1 |
| Followill, DS | 1 |
| Thwaites, DI | 1 |
| Izewska, J | 1 |
| Kang, JH | 1 |
| Yoon, Y | 1 |
| Song, J | 1 |
| Van de Winckel, A | 1 |
| Gauthier, L | 1 |
| Chao, CT | 1 |
| Lee, YH | 1 |
| Li, CM | 1 |
| Han, DS | 1 |
| Huang, JW | 1 |
| Huang, KC | 1 |
| Ni, L | 1 |
| Güttinger, R | 1 |
| Triana, CA | 1 |
| Spingler, B | 1 |
| Baldridge, KK | 1 |
| Patzke, GR | 1 |
| Shen, X | 1 |
| Wang, B | 1 |
| Xie, S | 1 |
| Deng, W | 1 |
| Wu, D | 1 |
| Zhang, Q | 1 |
| Voskamp, BJ | 1 |
| Peelen, MJCS | 1 |
| Ravelli, ACJ | 1 |
| van der Lee, R | 1 |
| Mol, BWJ | 1 |
| Pajkrt, E | 1 |
| Ganzevoort, W | 1 |
| Kazemier, BM | 1 |
| Tibrewala, R | 1 |
| Bahroos, E | 1 |
| Mehrabian, H | 1 |
| Foreman, SC | 1 |
| Link, TM | 1 |
| Pedoia, V | 1 |
| Majumdar, S | 1 |
| Jablonski, CL | 1 |
| Leonard, C | 1 |
| Salo, P | 1 |
| Krawetz, RJ | 1 |
| Yoon, N | 1 |
| Hong, SN | 1 |
| Cho, JG | 1 |
| Jeong, HK | 1 |
| Lee, KH | 1 |
| Park, HW | 1 |
| Barman, S | 1 |
| Konai, MM | 1 |
| Samaddar, S | 1 |
| Haldar, J | 1 |
| Mohamed, HSH | 1 |
| Li, CF | 1 |
| Hu, ZY | 1 |
| Deng, Z | 1 |
| Chen, LH | 1 |
| Su, BL | 1 |
| Chu, K | 1 |
| Liu, YP | 1 |
| Li, YB | 1 |
| Zhang, H | 1 |
| Xu, C | 1 |
| Zou, Z | 1 |
| Wu, Z | 1 |
| Xia, Y | 1 |
| Zhao, P | 1 |
| Wang, HT | 1 |
| de Biase, S | 1 |
| Pellitteri, G | 1 |
| Gigli, GL | 1 |
| Valente, M | 1 |
| Jenkins, RD | 1 |
| Aziz, JK | 1 |
| Gievers, LL | 1 |
| Mooers, HM | 1 |
| Fino, N | 1 |
| Rozansky, DJ | 1 |
| Bilchenko, О | 1 |
| Kravtsova, V | 1 |
| Samburh, Y | 1 |
| Hodlevska, O | 1 |
| Gavrilyuk, V | 1 |
| Takashi, Y | 1 |
| Koga, M | 1 |
| Matsuzawa, Y | 1 |
| Saito, J | 1 |
| Omura, M | 1 |
| Nishikawa, T | 1 |
| Izzo, JL | 1 |
| Hong, M | 1 |
| Hussain, T | 1 |
| Osmond, PJ | 1 |
| Cui, W | 1 |
| Zhang, HL | 1 |
| Hu, HJ | 1 |
| Zhang, YN | 1 |
| Liu, DM | 1 |
| Sayer, G | 1 |
| Bhat, G | 1 |
| Zhu, XQ | 1 |
| Hong, HS | 1 |
| Chen, LL | 1 |
| Li, YH | 1 |
| Sun, QL | 1 |
| Li, M | 1 |
| Rui, HL | 1 |
| Chen, YP | 1 |
| Güder, G | 1 |
| Hammer, F | 1 |
| Deutschbein, T | 1 |
| Brenner, S | 1 |
| Berliner, D | 1 |
| Deubner, N | 1 |
| Bidlingmaier, M | 1 |
| Ertl, G | 1 |
| Allolio, B | 1 |
| Angermann, CE | 1 |
| Fassnacht, M | 1 |
| Störk, S | 1 |
| Browne, GA | 1 |
| Griffin, TP | 1 |
| O'Shea, PM | 1 |
| Dennedy, MC | 1 |
| Kobalava, Z | 1 |
| Kotovskaya, Y | 1 |
| Averkov, O | 1 |
| Pavlikova, E | 1 |
| Moiseev, V | 1 |
| Albrecht, D | 1 |
| Chandra, P | 1 |
| Ayalasomayajula, S | 1 |
| Prescott, MF | 1 |
| Pal, P | 1 |
| Langenickel, TH | 1 |
| Jordaan, P | 1 |
| Rajman, I | 1 |
| Lasheen, NN | 1 |
| Mohamed, GF | 1 |
| Boonen, L | 1 |
| Verbrugge, FH | 1 |
| Nijst, P | 1 |
| Noyens, P | 1 |
| De Vusser, P | 1 |
| Verhaert, D | 1 |
| Van Lierde, J | 1 |
| Vrolix, M | 1 |
| Dupont, M | 1 |
| Mullens, W | 1 |
| Meijers, WC | 1 |
| van der Velde, AR | 1 |
| Muller Kobold, AC | 1 |
| Dijck-Brouwer, J | 1 |
| Wu, AH | 1 |
| Jaffe, A | 1 |
| de Boer, RA | 1 |
| Mendez, N | 1 |
| Halabi, D | 1 |
| Spichiger, C | 1 |
| Salazar, ER | 1 |
| Vergara, K | 1 |
| Alonso-Vasquez, P | 1 |
| Carmona, P | 1 |
| Sarmiento, JM | 1 |
| Richter, HG | 1 |
| Seron-Ferre, M | 1 |
| Torres-Farfan, C | 1 |
| Ichiki, T | 1 |
| Burnett, JC | 1 |
| Scott, CG | 1 |
| Heublein, DM | 1 |
| Miyata, M | 1 |
| Kinugawa, K | 1 |
| Inoue, T | 1 |
| Tei, C | 1 |
| Ruilope, LM | 1 |
| Lin, SL | 1 |
| Chen, YM | 1 |
| Chiang, WC | 1 |
| Wu, KD | 1 |
| Tsai, TJ | 2 |
| Morales, MA | 1 |
| Carvajal, CA | 1 |
| Ortiz, E | 1 |
| Mosso, LM | 1 |
| Artigas, RA | 1 |
| Owen, GI | 1 |
| Fardella, CE | 1 |
| Gandhi, MS | 2 |
| Deshmukh, PA | 2 |
| Kamalov, G | 2 |
| Zhao, T | 1 |
| Whaley, JT | 1 |
| Tichy, JR | 1 |
| Bhattacharya, SK | 2 |
| Ahokas, RA | 2 |
| Sun, Y | 2 |
| Gerling, IC | 2 |
| Weber, KT | 2 |
| MacArthur, CJ | 1 |
| Kempton, JB | 1 |
| DeGagne, J | 1 |
| Trune, DR | 1 |
| Rengo, G | 1 |
| Lymperopoulos, A | 1 |
| Zincarelli, C | 1 |
| Donniacuo, M | 1 |
| Soltys, S | 1 |
| Rabinowitz, JE | 1 |
| Koch, WJ | 1 |
| Klemmer, PJ | 1 |
| Bomback, AS | 1 |
| Cortinovis, M | 1 |
| Perico, N | 1 |
| Cattaneo, D | 1 |
| Remuzzi, G | 1 |
| Nardi, E | 1 |
| Palermo, A | 1 |
| Mulè, G | 1 |
| Cusimano, P | 1 |
| Cottone, S | 1 |
| Cerasola, G | 1 |
| Baburyan, NY | 1 |
| Johnson, PL | 1 |
| Jain, G | 1 |
| Campbell, RC | 1 |
| Warnock, DG | 2 |
| Borovkova, NIu | 2 |
| Borovkov, NN | 2 |
| Sidnev, BN | 2 |
| Obukhova, EO | 1 |
| Yamaji, M | 1 |
| Tsutamoto, T | 2 |
| Kawahara, C | 1 |
| Nishiyama, K | 1 |
| Yamamoto, T | 5 |
| Fujii, M | 2 |
| Horie, M | 2 |
| Murphy, SC | 1 |
| Agger, S | 1 |
| Rainey, PM | 1 |
| Arlet, JB | 1 |
| Hunter, RG | 2 |
| Bloss, EB | 1 |
| McCarthy, KJ | 1 |
| McEwen, BS | 2 |
| Nagase, M | 2 |
| Fujita, T | 2 |
| Palmer, BF | 1 |
| Toto, RD | 1 |
| Salt, AN | 1 |
| Plontke, SK | 1 |
| Sahni, V | 1 |
| Rosa, RM | 1 |
| Batlle, D | 1 |
| Volpe, M | 1 |
| Francia, P | 1 |
| Tocci, G | 1 |
| Rubattu, S | 1 |
| Cangianiello, S | 1 |
| Elena Rao, MA | 1 |
| Trimarco, B | 1 |
| Condorelli, M | 1 |
| Abe, M | 1 |
| Okada, K | 1 |
| Maruyama, N | 1 |
| Matsumoto, S | 1 |
| Maruyama, T | 1 |
| Matsumoto, K | 1 |
| Soma, M | 1 |
| Elabida, B | 1 |
| Edwards, A | 1 |
| Salhi, A | 1 |
| Azroyan, A | 1 |
| Fodstad, H | 1 |
| Meneton, P | 1 |
| Doucet, A | 1 |
| Bloch-Faure, M | 1 |
| Crambert, G | 1 |
| Bertocchio, JP | 1 |
| Brem, AS | 1 |
| Morris, DJ | 1 |
| Gong, R | 1 |
| Nappi, JM | 1 |
| Sieg, A | 1 |
| Balavoine, AS | 1 |
| Bataille, P | 1 |
| Vanhille, P | 1 |
| Azar, R | 1 |
| Noël, C | 1 |
| Asseman, P | 1 |
| Soudan, B | 1 |
| Wémeau, JL | 1 |
| Vantyghem, MC | 1 |
| Zhou, X | 1 |
| Crook, MF | 1 |
| Sharif-Rodriguez, W | 1 |
| Zhu, Y | 1 |
| Ruben, Z | 1 |
| Pan, Y | 1 |
| Urosevic-Price, O | 1 |
| Wang, L | 1 |
| Flattery, AM | 1 |
| Forrest, G | 1 |
| Szeto, D | 1 |
| Zhao, H | 1 |
| Roy, S | 1 |
| Forrest, MJ | 1 |
| Przybyła, A | 1 |
| Czarnecka, D | 1 |
| Kusiak, A | 1 |
| Wiliński, J | 1 |
| Sondej, T | 1 |
| Jastrzebski, M | 1 |
| Kawecka-Jaszcz, K | 1 |
| Graffe, CC | 1 |
| Bech, JN | 2 |
| Lauridsen, TG | 1 |
| Pedersen, EB | 8 |
| Niebylski, A | 1 |
| Boccolini, A | 1 |
| Bensi, N | 1 |
| Binotti, S | 1 |
| Hansen, C | 1 |
| Yaciuk, R | 1 |
| Gauna, H | 1 |
| Tomaschitz, A | 1 |
| Ritz, E | 1 |
| Pieske, B | 1 |
| Fahrleitner-Pammer, A | 1 |
| Kienreich, K | 1 |
| Horina, JH | 1 |
| Drechsler, C | 1 |
| März, W | 1 |
| Ofner, M | 1 |
| Pieber, TR | 1 |
| Pilz, S | 1 |
| Jorde, UP | 1 |
| Vittorio, T | 1 |
| Katz, SD | 1 |
| Colombo, PC | 1 |
| Latif, F | 1 |
| Le Jemtel, TH | 1 |
| Feria, I | 1 |
| Pichardo, I | 1 |
| Juárez, P | 1 |
| Ramírez, V | 1 |
| González, MA | 1 |
| Uribe, N | 1 |
| García-Torres, R | 1 |
| López-Casillas, F | 1 |
| Gamba, G | 1 |
| Bobadilla, NA | 1 |
| Ibrahim, HN | 2 |
| Hostetter, TH | 3 |
| Pedersen, RS | 1 |
| Bentzen, H | 1 |
| Nyvad, O | 1 |
| Albåge, A | 1 |
| Kennebäck, G | 1 |
| van der Linden, J | 1 |
| Berglund, H | 2 |
| Lopes, ME | 1 |
| Le Corvoisier, P | 1 |
| Tabet, JY | 1 |
| Su, JB | 1 |
| Badoual, T | 1 |
| Cachin, JC | 1 |
| Merlet, P | 1 |
| Castaigne, A | 1 |
| Hittinger, L | 1 |
| Meune, C | 1 |
| Mahé, I | 1 |
| Mourad, JJ | 1 |
| Cohen-Solal, A | 1 |
| Levy, B | 1 |
| Kevorkian, JP | 1 |
| Jondeau, G | 1 |
| Habib, A | 1 |
| Lebret, M | 1 |
| Knellwolf, AL | 1 |
| Simoneau, G | 1 |
| Caulin, C | 1 |
| Bergmann, JF | 1 |
| Cohn, JN | 2 |
| Anand, IS | 1 |
| Latini, R | 1 |
| Masson, S | 1 |
| Chiang, YT | 1 |
| Glazer, R | 1 |
| SURIANI, L | 1 |
| GARAGNANI, A | 1 |
| BRILLANTE, C | 1 |
| ARTUSO, P | 1 |
| LEPRAT, J | 1 |
| Kedzierska, K | 1 |
| Ciechanowski, K | 1 |
| Gołembiewska, E | 1 |
| Domański, L | 1 |
| Kabat-Koperska, J | 1 |
| Pietrzak-Nowacka, M | 1 |
| Stepień-Korzonek, M | 1 |
| Bober, J | 1 |
| Struthers, AD | 6 |
| Huang, Y | 1 |
| Hunyor, SN | 1 |
| Jiang, L | 1 |
| Kawaguchi, O | 1 |
| Shirota, K | 1 |
| Ikeda, Y | 1 |
| Yuasa, T | 1 |
| Gallagher, G | 1 |
| Zeng, B | 1 |
| Zheng, X | 1 |
| Krum, H | 1 |
| Liew, D | 1 |
| Vetshev, SP | 1 |
| Polunin, GV | 1 |
| Sotnikova, VA | 1 |
| Saito, Y | 1 |
| Yamada, T | 1 |
| Kuno, A | 1 |
| Ogawa, K | 1 |
| Tang, M | 1 |
| Masuda, K | 1 |
| Nakamura, S | 1 |
| Ando, T | 1 |
| Okamoto, T | 1 |
| Ohara, H | 1 |
| Nomura, T | 1 |
| Joh, T | 1 |
| Shirai, T | 1 |
| Itoh, M | 1 |
| Neuberger, HR | 1 |
| Schotten, U | 1 |
| Verheule, S | 1 |
| Eijsbouts, S | 1 |
| Blaauw, Y | 1 |
| van Hunnik, A | 1 |
| Allessie, M | 1 |
| Yano, M | 1 |
| Grippo, AJ | 1 |
| Francis, J | 1 |
| Beltz, TG | 1 |
| Felder, RB | 1 |
| Johnson, AK | 1 |
| El-Raziky, MS | 1 |
| Gohar, N | 1 |
| El-Raziky, M | 1 |
| Ishikawa, C | 1 |
| Wada, A | 1 |
| Ohno, K | 1 |
| Sakai, H | 1 |
| Skvortsov, AA | 2 |
| Nasonova, SN | 2 |
| Sychev, AV | 2 |
| Arbolishvili, GN | 1 |
| Baklanova, NA | 2 |
| Mareev, VIu | 2 |
| Belenkov, IuN | 2 |
| van de Wal, RM | 1 |
| Asselbergs, FW | 1 |
| Plokker, HW | 1 |
| Smilde, TD | 1 |
| Lok, D | 1 |
| van Veldhuisen, DJ | 3 |
| van Gilst, WH | 1 |
| Voors, AA | 1 |
| Coca, SG | 1 |
| Perazella, MA | 1 |
| Ohnaka, K | 1 |
| Takayanagi, R | 1 |
| Orlova, IaA | 1 |
| Masenko, VP | 2 |
| Maduwegedera, D | 1 |
| Kett, MM | 1 |
| Flower, RL | 1 |
| Lambert, GW | 1 |
| Bertram, JF | 1 |
| Wintour, EM | 1 |
| Denton, KM | 1 |
| Duhaney, TA | 2 |
| Cui, L | 1 |
| Rude, MK | 1 |
| Lebrasseur, NK | 1 |
| Ngoy, S | 1 |
| De Silva, DS | 1 |
| Siwik, DA | 1 |
| Liao, R | 1 |
| Sam, F | 2 |
| Bellani, R | 1 |
| Bloss, E | 1 |
| Costa, A | 1 |
| Romeo, RD | 1 |
| Biolo, A | 1 |
| Chao, T | 1 |
| Kotlyar, E | 1 |
| Allensworth-Davies, D | 1 |
| Loscalzo, J | 1 |
| Wang, W | 1 |
| Soltero, L | 1 |
| Zhang, P | 1 |
| Huang, XR | 1 |
| Lan, HY | 1 |
| Adrogue, HJ | 1 |
| Ponda, MP | 1 |
| Ishimitsu, T | 1 |
| Kameda, T | 1 |
| Akashiba, A | 1 |
| Takahashi, T | 1 |
| Ohta, S | 1 |
| Yoshii, M | 1 |
| Minami, J | 1 |
| Ono, H | 1 |
| Numabe, A | 1 |
| Matsuoka, H | 1 |
| Cincunegui, LM | 1 |
| Ituarte, LM | 1 |
| Viera, TB | 1 |
| Ibañez, JE | 1 |
| Carra, GE | 1 |
| Saldeña, TA | 1 |
| Saravi, FD | 1 |
| Seed, A | 1 |
| Gardner, R | 1 |
| McMurray, J | 1 |
| Hillier, C | 1 |
| Murdoch, D | 1 |
| MacFadyen, R | 1 |
| Bobillier, A | 1 |
| Mann, J | 1 |
| McDonagh, T | 1 |
| Hayashi, M | 1 |
| Kitajima, W | 1 |
| Saruta, T | 2 |
| Fitzpatrick, D | 1 |
| Nicholls, MG | 1 |
| Ikram, H | 1 |
| Espiner, EA | 2 |
| Shul'ga, VA | 1 |
| Slavnov, VN | 1 |
| Efimov, AS | 1 |
| Iakovlev, AA | 1 |
| Wenting, GJ | 1 |
| Man in't veld, AJ | 1 |
| Woittiez, AJ | 1 |
| Boomsma, F | 2 |
| Laird-Meeter, K | 1 |
| Simoons, ML | 1 |
| Hugenholtz, PG | 1 |
| Schalekamp, MA | 1 |
| Gentilini, P | 1 |
| Sicuteri, F | 1 |
| Laffi, G | 1 |
| La Villa, G | 1 |
| Smorlesi, C | 1 |
| Del Bianco, PL | 1 |
| Fanciullacci, M | 1 |
| Curradi, C | 1 |
| Ueda, K | 1 |
| Sakai, M | 1 |
| Matsushita, S | 1 |
| Kuwajima, I | 1 |
| Murakami, M | 1 |
| Ali, AS | 1 |
| Beretta-Piccoli, C | 1 |
| Weidmann, P | 1 |
| Schiffl, H | 1 |
| Reubi, FC | 1 |
| Burke, M | 1 |
| Papo, J | 1 |
| Stavorovsky, M | 1 |
| Almog, C | 1 |
| Kutyrina, IM | 4 |
| Nikishova, TA | 2 |
| Livshits, NL | 1 |
| Klepikov, PV | 1 |
| Nishioka, A | 2 |
| Kubo, S | 2 |
| Hirota, Y | 1 |
| Kawamura, K | 1 |
| Takatsu, T | 2 |
| Korkushko, OV | 1 |
| Kalinovskaia, EG | 1 |
| Asinova, MI | 1 |
| Sharpe, DN | 1 |
| Coxon, R | 1 |
| Androsova, SO | 2 |
| Warshavskii, VA | 1 |
| Tareyeva, IE | 1 |
| Sellars, L | 1 |
| Shore, AC | 1 |
| Wilkinson, R | 1 |
| James, OF | 1 |
| Robson, V | 1 |
| Kutsenko, AI | 1 |
| Shpil'kin, VM | 1 |
| Boiadzhan, PP | 1 |
| Levitskaia, IuV | 1 |
| Shapkina, LS | 1 |
| Schambelan, M | 3 |
| Sebastian, A | 1 |
| Biglieri, EG | 2 |
| Khodarev, NN | 2 |
| Filatov, VI | 1 |
| Iosava, LI | 1 |
| Hsieh, BS | 1 |
| Chen, WY | 1 |
| Yen, TS | 1 |
| Nishimura, H | 1 |
| Sonotani, N | 1 |
| Gerasimov, GM | 3 |
| Martyniuk, AD | 2 |
| Cruz-Hernandez, JJ | 1 |
| Diez-Jarilla, JL | 1 |
| Pino, J | 1 |
| Laso, FJ | 1 |
| Vasil'eva, LN | 1 |
| Cody, RJ | 2 |
| Franklin, KW | 1 |
| Laragh, JH | 3 |
| Alekseev, VG | 1 |
| Tikhomirov, ES | 1 |
| Elenkova, A | 1 |
| Stefanov, G | 1 |
| Radó, JP | 2 |
| van Wimersma Greidanus, TB | 1 |
| Boer, P | 1 |
| Mees, EJ | 1 |
| Korolenko, SS | 1 |
| Rudka, R | 1 |
| Kokot, F | 1 |
| Wiecek, A | 1 |
| Marcinkowski, W | 1 |
| Trembecki, J | 1 |
| Barr, CS | 2 |
| Naas, A | 1 |
| Freeman, M | 1 |
| Lang, CC | 1 |
| Tietze, IN | 1 |
| Muiesan, ML | 2 |
| Boni, E | 1 |
| Castellano, M | 2 |
| Beschi, M | 2 |
| Cefis, G | 1 |
| Cerri, B | 2 |
| Verdecchia, P | 1 |
| Porcellati, C | 1 |
| Pollavini, G | 2 |
| Agabiti-Rosei, E | 2 |
| John, EG | 1 |
| Fornell, LC | 1 |
| Radhakrishnan, J | 1 |
| Anutrakulchai, S | 1 |
| Jonasson, O | 1 |
| Colice, GL | 1 |
| Lawrason, J | 1 |
| Munsef, A | 1 |
| Bittle, P | 1 |
| Dietz, J | 1 |
| Ramirez, G | 1 |
| Uemasu, J | 2 |
| Fujihara, M | 1 |
| Matsumoto, T | 1 |
| Kawasaki, H | 3 |
| Fujiwara, M | 1 |
| Asakuma, S | 1 |
| Nakamura, T | 1 |
| Nakamura, K | 2 |
| Iwasaki, T | 1 |
| Szabó, BM | 1 |
| van der Burgh, PH | 1 |
| Kruik, J | 1 |
| Girbes, AR | 2 |
| Lie, KI | 1 |
| De Nicola, L | 1 |
| Bellizzi, V | 1 |
| Cianciaruso, B | 1 |
| Minutolo, R | 1 |
| Colucci, G | 1 |
| Balletta, M | 1 |
| Fuiano, G | 1 |
| Conte, G | 1 |
| MacFadyen, RJ | 1 |
| Sturrock, ND | 1 |
| Fenwick, M | 1 |
| Villarreal, D | 3 |
| Freeman, RH | 3 |
| Habibullah, AA | 1 |
| Simmons, JC | 1 |
| Kudoh, A | 1 |
| Kudo, M | 1 |
| Ishihara, H | 1 |
| Matsuki, A | 1 |
| Duprez, DA | 1 |
| De Buyzere, ML | 1 |
| Rietzschel, ER | 1 |
| Taes, Y | 1 |
| Clement, DL | 1 |
| Morgan, D | 1 |
| Jablecka, A | 1 |
| Chmara, E | 1 |
| Korzeniowska, K | 1 |
| Verheul, J | 1 |
| Segenhout, JM | 1 |
| Dunnebier, EA | 1 |
| Albers, FW | 1 |
| Blaauw, EH | 1 |
| Wit, HP | 1 |
| Westheim, AS | 1 |
| Bostrøm, P | 1 |
| Christensen, CC | 1 |
| Parikka, H | 1 |
| Rykke, EO | 1 |
| Toivonen, L | 1 |
| Ortiz, RM | 1 |
| Wang, TJ | 1 |
| Wade, CE | 1 |
| Hillege, HL | 1 |
| de Kam, PJ | 1 |
| de Zeeuw, D | 1 |
| Charlesworth, A | 1 |
| Hampton, JR | 1 |
| Manunta, P | 1 |
| Hamilton, J | 1 |
| Rogowski, AC | 1 |
| Hamilton, BP | 1 |
| Hamlyn, JM | 1 |
| Henger, A | 1 |
| Tutt, P | 1 |
| Riesen, WF | 1 |
| Hulter, HN | 1 |
| Krapf, R | 1 |
| Pignatelli, D | 1 |
| Maia, M | 1 |
| Castro, AR | 1 |
| da Conceição Magalhães, M | 1 |
| Vivier, J | 1 |
| Defaye, G | 1 |
| Cicoira, M | 2 |
| Zanolla, L | 2 |
| Rossi, A | 2 |
| Golia, G | 2 |
| Franceschini, L | 2 |
| Cabrini, G | 1 |
| Bonizzato, A | 1 |
| Graziani, M | 1 |
| Anker, SD | 1 |
| Coats, AJ | 1 |
| Zardini, P | 2 |
| Nagaya, N | 1 |
| Uematsu, M | 1 |
| Kojima, M | 1 |
| Date, Y | 1 |
| Nakazato, M | 1 |
| Okumura, H | 1 |
| Hosoda, H | 1 |
| Shimizu, W | 1 |
| Yamagishi, M | 1 |
| Oya, H | 1 |
| Koh, H | 1 |
| Yutani, C | 1 |
| Kangawa, K | 1 |
| Goette, A | 1 |
| Hoffmanns, P | 1 |
| Enayati, W | 1 |
| Meltendorf, U | 1 |
| Geller, JC | 1 |
| Klein, HU | 1 |
| Zeni, P | 1 |
| Caruso, B | 1 |
| Palmieri, EA | 1 |
| Biondi, B | 1 |
| Fazio, S | 1 |
| Knowlen, GG | 1 |
| Kittleson, MD | 1 |
| Nachreiner, RF | 1 |
| Eyster, GE | 1 |
| Xiu, JC | 1 |
| Wu, P | 1 |
| Xu, JP | 1 |
| Guo, Z | 1 |
| Lai, W | 1 |
| Liu, Y | 1 |
| Ivkov, VG | 1 |
| van Ypersele de Strihou, C | 1 |
| Dieu, JP | 1 |
| Gonzalez, JJ | 1 |
| Werk, EE | 1 |
| Thrasher, K | 1 |
| Behar, R | 1 |
| Loadholt, CB | 1 |
| Scavo, D | 1 |
| Cugini, P | 1 |
| Manconi, R | 1 |
| Serdoz, R | 1 |
| Szende, L | 1 |
| Szucs, L | 1 |
| Mizuno, K | 1 |
| Sakaue, M | 1 |
| Matsui, JI | 1 |
| Haruyama, K | 1 |
| Nakajima, K | 1 |
| Fukuchi, S | 1 |
| Okeanova, TA | 1 |
| Marova, EI | 1 |
| Atamanova, TM | 1 |
| Gerdes, H | 1 |
| Sidorenko, BA | 1 |
| Kudisov, IuM | 1 |
| Rossel's, AN | 1 |
| Razumova, ET | 1 |
| Drozdova, ES | 1 |
| Nosova, NP | 1 |
| Kazanova, LR | 1 |
| Ubrantsev, VA | 1 |
| Zipser, RD | 1 |
| Hoefs, JC | 1 |
| Speckart, PF | 1 |
| Zia, PK | 1 |
| Horton, R | 1 |
| Gerasimenko, PP | 4 |
| McGrath, BP | 1 |
| Tiller, DJ | 1 |
| Bune, A | 1 |
| Chalmers, JP | 1 |
| Korner, PI | 1 |
| Uther, JB | 1 |
| Kahn, T | 1 |
| Kaji, DM | 1 |
| Nicolis, G | 1 |
| Krakoff, LR | 1 |
| Stein, RM | 1 |
| Rachinskiĭ, ID | 1 |
| Bock, KD | 1 |
| Cremer, W | 1 |
| Werner, U | 1 |
| Bravo, EL | 1 |
| Tarazi, RC | 1 |
| Dustan, HP | 1 |
| Mersey, JH | 1 |
| Williams, GH | 1 |
| Hollenberg, NK | 1 |
| Dluhy, RG | 1 |
| Farber, MO | 1 |
| Kiblawi, SS | 1 |
| Strawbridge, RA | 1 |
| Robertson, GL | 1 |
| Weinberger, MH | 1 |
| Manfredi, F | 1 |
| Schroeder, ET | 1 |
| Anderson, GH | 1 |
| Goldman, SH | 1 |
| Streeten, DH | 1 |
| Kajiwara, N | 1 |
| Vinogradova, LA | 2 |
| Daniliak, IG | 1 |
| Shushliapin, OI | 2 |
| Vlasenko, MA | 1 |
| Brass, H | 1 |
| Ochs, HG | 1 |
| Armbruster, H | 1 |
| Heintz, R | 1 |
| Paunier, L | 1 |
| Sizonenko, PC | 1 |
| Iunda, IF | 2 |
| Proskura, OV | 1 |
| Imshinetskaia, LP | 2 |
| Obodynskaia, LI | 1 |
| Selivonenko, VG | 1 |
| Sholokh, SG | 1 |
| Morozov, AI | 1 |
| Nicholls, DP | 1 |
| Riley, M | 1 |
| Elborn, JS | 1 |
| Stanford, CF | 1 |
| Shaw, C | 1 |
| McKillop, JM | 1 |
| Buchanan, KD | 1 |
| Khaĭdarova, GKh | 1 |
| Tomashets, EA | 1 |
| Mazur, NA | 1 |
| Riabov, SI | 3 |
| Gadaev, A | 2 |
| Kotovoĭ, IuO | 3 |
| Kucher, AG | 3 |
| Degtereva, OA | 2 |
| Kaiukov, IG | 3 |
| Uchihara, M | 1 |
| Izumi, N | 1 |
| Sato, C | 1 |
| Marumo, F | 1 |
| Romanelli, G | 1 |
| Cefis, M | 1 |
| Muiesan, G | 1 |
| Kageyama, Y | 2 |
| Sakharchuk, II | 1 |
| Tsygankov, AT | 1 |
| Korchinskaia, OI | 1 |
| Voci, P | 1 |
| Bilotta, F | 1 |
| Viola, R | 1 |
| Clarke, NW | 1 |
| Jones, DA | 1 |
| Tames, F | 1 |
| Laing, I | 1 |
| George, NJ | 1 |
| Kimura, T | 1 |
| Ota, K | 1 |
| Shoji, M | 1 |
| Inoue, M | 1 |
| Sato, K | 1 |
| Ohta, M | 1 |
| Saito, T | 1 |
| Abe, K | 1 |
| Yoshinaga, K | 1 |
| Gibbs, JS | 1 |
| Ferrari, R | 1 |
| Keegan, J | 1 |
| Ceconi, C | 1 |
| Wright, C | 1 |
| Fox, KM | 1 |
| Poole-Wilson, PA | 1 |
| Suzuki, H | 1 |
| Lukutina, LV | 1 |
| Stuks, IIu | 1 |
| Lishmanov, IuB | 1 |
| Maslov, LN | 1 |
| Manchakidi, GA | 1 |
| Brands, MW | 2 |
| Boukter, S | 1 |
| Theodorsson, E | 1 |
| Vallin, H | 1 |
| Edhag, O | 1 |
| Mileva, Zh | 1 |
| Maleeva, A | 1 |
| Khristov, G | 1 |
| Costa, FV | 1 |
| Borghi, C | 1 |
| Boschi, S | 1 |
| Mussi, A | 1 |
| Ambrosioni, E | 1 |
| Shulutko, BI | 1 |
| Konstantinov, IuV | 1 |
| Gavrisiuk, VK | 1 |
| Bezdvernyĭ, IuI | 1 |
| Morozova, NA | 1 |
| Didenko, SO | 1 |
| Torres, VE | 1 |
| Young, WF | 1 |
| Offord, KP | 1 |
| Hattery, RR | 1 |
| Martin, IH | 1 |
| Basso, N | 1 |
| Sarchi, MI | 1 |
| Taquini, AC | 1 |
| Fontana, F | 1 |
| Spagnolo, N | 1 |
| Capelli, M | 1 |
| Bernardi, P | 1 |
| Insel, J | 1 |
| Mirvis, DM | 1 |
| Boland, MJ | 1 |
| Cinquegrani, MP | 1 |
| Shanes, J | 1 |
| Rubin, SA | 1 |
| Whalen, JJ | 1 |
| Dustov, AD | 1 |
| Brilla, CG | 1 |
| Krämer, B | 1 |
| Hoffmeister, HM | 1 |
| Müller-Schauenburg, W | 1 |
| Risler, T | 1 |
| Seipel, L | 1 |
| Nakamata, M | 1 |
| Tsukioka, K | 1 |
| Hashimoto, T | 1 |
| Kirlin, PC | 2 |
| Dansby, C | 2 |
| Laird, C | 1 |
| Willis, PW | 2 |
| Hodsman, GP | 1 |
| Kohzuki, M | 1 |
| Howes, LG | 1 |
| Sumithran, E | 1 |
| Tsunoda, K | 1 |
| Johnston, CI | 1 |
| Lohmeier, TE | 1 |
| Montani, JP | 1 |
| Smith, MJ | 1 |
| Rushing, EL | 1 |
| Garcia, R | 1 |
| Thibault, G | 1 |
| Gutkowska, J | 1 |
| Cantin, M | 1 |
| Eiskjaer, H | 1 |
| Rasmussen, LM | 1 |
| Jespersen, B | 2 |
| Danielsen, H | 4 |
| Sørensen, SS | 1 |
| Maeda, N | 1 |
| Hirayama, C | 2 |
| Kobayashi, T | 1 |
| Sakurai, H | 1 |
| Loginov, AS | 1 |
| Astaf'eva, OV | 1 |
| Ikeda, T | 1 |
| Gomi, T | 1 |
| Yuhara, M | 1 |
| Sakurai, J | 1 |
| Nakayama, D | 1 |
| Laird, CK | 1 |
| Sauder, SE | 1 |
| Kelch, RP | 1 |
| Grekin, RJ | 1 |
| Kelsch, RC | 1 |
| Fedirko, MI | 1 |
| Ershova, GS | 1 |
| Starzyk, J | 1 |
| Kowalski, D | 1 |
| Kowalska, K | 1 |
| Murawaki, Y | 1 |
| Covit, AB | 1 |
| Schaer, GL | 1 |
| Sealey, JE | 1 |
| Feldschuh, J | 1 |
| Markov, KhM | 1 |
| Kucherenko, AG | 1 |
| Aralov, MD | 1 |
| Briazgunov, IP | 1 |
| Iatsyk, PK | 1 |
| Barabanov, LG | 1 |
| Scandling, JD | 1 |
| Ornt, DB | 1 |
| Andreucci, VE | 1 |
| Dal Canton, A | 1 |
| Russo, D | 1 |
| Veniero, P | 1 |
| Oliva, O | 1 |
| Cofelice, E | 1 |
| Romano, G | 1 |
| Kharchenko, VI | 1 |
| Liusov, VA | 1 |
| Petraneva, EV | 1 |
| Evsikov, EM | 1 |
| Postnov, IIu | 1 |
| Abildgaard, U | 1 |
| Aldershvile, J | 1 |
| Ring-Larsen, H | 1 |
| Falk, J | 1 |
| Christensen, NJ | 1 |
| Giese, J | 1 |
| Hammer, M | 1 |
| Henriksen, JH | 1 |
| Tareeva, IE | 1 |
| Mertin, J | 1 |
| Koczorek, KR | 1 |
| Backmund, H | 1 |
| Tucci, JR | 1 |
| Jagger, PI | 1 |
| Pauk, GL | 1 |
| Lauler, DP | 1 |
| Fleischer, N | 1 |
| Brown, H | 1 |
| Graham, DY | 1 |
| Deleña, S | 1 |
| Okano, M | 1 |
| Tanaka, T | 1 |
| Kobayashi, H | 1 |
| Honda, H | 1 |
| Fukuda, T | 1 |
| Miyama, S | 1 |
| Schirmeister, J | 1 |
| Koletsky, S | 1 |
| Kukes, VG | 2 |
| Men'shikov, VV | 2 |
| Sivkov, II | 2 |
| Shishov, VI | 1 |
| Kusukawa, R | 1 |
| Kinoshita, M | 2 |
| Kuntz, E | 1 |
| de Portugal, J | 1 |
| Perezagua, C | 1 |
| Velasco, A | 1 |
| Shapiro, AP | 1 |
| Leenen, FH | 1 |
| Galla, SJ | 1 |
| Redmond, DP | 1 |
| Vagnucci, AH | 2 |
| McDonald, RH | 1 |
| Guyton, AC | 1 |
| Cowley, AW | 1 |
| Fagard, R | 1 |
| Langford, HG | 1 |
| McCaa, RE | 1 |
| DeClue, JW | 1 |
| Coleman, TG | 1 |
| Barnes, GE | 1 |
| Bel, A | 1 |
| Rousset, H | 1 |
| Fournier, G | 1 |
| Peleshchuk, AP | 1 |
| Kraus, M | 1 |
| Erdösová, R | 1 |
| Hitzenberger, G | 1 |
| Saimyoji, H | 1 |
| Seriu, Y | 1 |
| Takayasu, M | 1 |
| Wildhirt, E | 1 |
| Vaughan, ED | 1 |
| Bühler, FR | 1 |
| Rudyk, BI | 1 |
| Claus-Walker, J | 1 |
| Vallbona, C | 1 |
| Carter, RE | 1 |
| Lipscomb, HS | 1 |
| McCredie, DA | 1 |
| Blair-West, JR | 1 |
| Scoggins, BA | 1 |
| Shipman, R | 1 |
| Golubchenko, AK | 1 |
| Revutskiĭ, BI | 1 |
| Nechaev, EN | 1 |
| Nagasaka, M | 1 |
| Kinouchi, T | 1 |
| Kurosawa, T | 1 |
| Ito, T | 1 |
| Walker, JC | 1 |
| Savoshchenko, IS | 1 |
| Fursova, GA | 1 |
| Miagkova, LP | 1 |
| Egart, FM | 1 |
| Slaton, PE | 1 |
| Stockigt, JR | 1 |
| Gneushev, ET | 1 |
| Gritti, FM | 1 |
| Agnoli, GC | 1 |
| Descovich, GC | 1 |
| Lodi, A | 1 |
| Manetti, R | 1 |
| Vikhert, AM | 1 |
| Ushkalov, AF | 1 |
| Vecsei, P | 1 |
| Düsterdieck, G | 1 |
| Jahnecke, J | 1 |
| Lommer, D | 1 |
| Wolff, HP | 1 |
| Vetter, K | 1 |
| Kettler, LH | 1 |
| Kaschube, I | 1 |
| Lüder, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open Label, Non-randomised Study to Explore Safety/Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 in Patients With Stable Heart Failure[NCT00913653] | Phase 2 | 30 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| Diuretic Efficiency in Patients With Stable Heart Failure: Ion Excretion Capacity of the Kidneys (DIPSTICK) Study[NCT02288819] | 50 participants (Actual) | Interventional | 2014-09-30 | Terminated (stopped due to Slow recruitment and a lack of funding to complete further follow-up) | |||
| Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)[NCT02297048] | Phase 4 | 26 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
| Renal Ageing-sarcopenia Network: a Combined Genetic, Immunological and Psychological Approach to Dissect Frailty[NCT04630132] | 1,500 participants (Anticipated) | Observational | 2017-03-25 | Recruiting | |||
| Genetic Predisposition of Chronic Nephrotoxicity From Calcineurin Inhibitors in Liver Transplant Recipients, Potential Correlation With Urinary Biomarkers[NCT00857844] | 207 participants (Actual) | Observational | 2007-07-31 | Completed | |||
| Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure[NCT02133105] | Phase 3 | 33 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
| The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity[NCT02896309] | 45 participants (Actual) | Interventional | 2016-09-30 | Completed | |||
| Exercise Intolerance in Elderly Diastolic Heart Failure[NCT00123955] | Phase 3 | 80 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
| Acute Kidney Injury and Nonsteroidal Anti-inflammatory Drugs in Patients Undergoing High-risk Abdominal or Thoracic Surgery[NCT02553174] | 50 participants (Actual) | Observational | 2016-06-01 | Terminated (stopped due to unable to recruit sufficient patients to satisfy study protocols) | |||
| Pathophysiologic and Outcomes Impact of the Relation of Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure - Pathway to More Individualized Therapy[NCT04156854] | 15 participants (Actual) | Interventional | 2020-01-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
"NYHA class is a semi-quantitative measurement of functional capacity on a scale from 1 to 4:~No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).~Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).~Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.~Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.~For the purpose of this outcome parameter, the patient is contacted by phone 30 days after baseline and NYHA functional class is assessed by a study investigator." (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | units on a scale from 1 to 4 (Mean) |
|---|---|
| Loop Diuretic Downtitration | 1.41 |
Unplanned hospital admission for symptoms of congestion and/or low output heart failure requiring either intravenous therapy and/or increase of oral diuretics. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
Dose increase of oral maintenance therapy with loop diuretics compared to the final dose achieved in the study 7 days after baseline. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
After baseline evaluation, loop diuretics are temporarily downtitrated or stopped for 7 consecutive days. The patient is instructed to measure his/her weight in the morning of these days, immediately after waking up, on the same balance. In case of weight increase >1,5 kg, the original dose of diuretics is restored. To check this, patients are contacted by phone after 3 and 7 days. If the patient has not gained >1,5 kg of weight after 7 days, loop diuretics are considered to be successfully downtitrated. (NCT02288819)
Timeframe: 7 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 37 |
The patient is contacted by phone 30 days after baseline and asked for self-reported presence of lower leg edema. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 1 |
The patient is contacted by phone 30 days after baseline and asked for self-reported orthopnea. (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | Participants (Count of Participants) |
|---|---|
| Loop Diuretic Downtitration | 5 |
Weight change [kg] 30 days after baseline compared to weight 7 days after baseline (after achieving the final dose of loop diuretics). (NCT02288819)
Timeframe: 30 days after baseline
| Intervention | kg (Mean) |
|---|---|
| Loop Diuretic Downtitration | -0.261 |
Weight change [kg] 7 days after baseline compared to baseline weight. (NCT02288819)
Timeframe: 7 days after baseline
| Intervention | kg (Mean) |
|---|---|
| Loop Diuretic Downtitration | 0.502 |
"Left ventricle measurements by MRI:~Mass/end diastolic volume ratio: g/ml" (NCT00123955)
Timeframe: Baseline, 9 month
| Intervention | g/ml (Mean) | |
|---|---|---|
| baseline | 9 month | |
| Placebo | 1.7 | 1.6 |
| Spironolactone | 1.8 | 1.7 |
Peak exercise VO2 (NCT00123955)
Timeframe: Baseline, 4 and 9 months
| Intervention | ml/kg/min (Mean) | ||
|---|---|---|---|
| Baseline | 4 months | 9 months | |
| Placebo | 13.3 | 13.5 | 13.9 |
| Spironolactone | 13.5 | 13.6 | 13.8 |
"Echocardiography Doppler measurement of left ventricular diastolic function:~Early mitral annulus velocity (lateral) (Ea; cm/s)" (NCT00123955)
Timeframe: Baseline, 4 month and 9 month
| Intervention | cm/s (Mean) | ||
|---|---|---|---|
| baseline | 4 month | 9 month | |
| Placebo | 6.8 | 6.8 | 6.6 |
| Spironolactone | 7.0 | 7.0 | 7.4 |
"The Minnesota Living with Heart Failure Questionnaire (MLHF) is a self-administered disease-specific questionnaire for patients with Heart Failure, comprising 21 items rated on six-point Likert scales, representing different degrees of impact of HF on HRQoL, from 0 (none) to 5 (very much). It provides a total score (range 0-105, from best to worst HRQoL), as well as scores for two dimensions, physical (8 items, range 0-40) and emotional (5 items, range 0-25). The other eight items (of the total of 21) are only considered for the calculation of the total score.~Scale of 0-105:The higher the score the worse the heart failure related Quality of Life." (NCT00123955)
Timeframe: Baseline, 4 and 9 months
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Baseline | 4 months | Final- 9 months | |
| Placebo | 28 | 29 | 25 |
| Spironolactone | 32 | 29 | 29 |
38 reviews available for aldosterone and Chronic Illness
| Article | Year |
|---|---|
Chronic hypertension and superimposed preeclampsia: screening and diagnosis.
Topics: Aldosterone; Angiogenic Proteins; Biomarkers; Chronic Disease; Cytokines; Female; Humans; Hypertensi | 2022 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P | 2019 |
The renin-angiotensin-aldosterone system and heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 2014 |
Extracellular volume and aldosterone interaction in chronic kidney disease.
Topics: Aldosterone; Cardiovascular Diseases; Chronic Disease; Extracellular Fluid; Fibrosis; Humans; Inflam | 2009 |
Aldosterone and progression of kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Clinical Trials as Topic; Disease Models, Animal; Disease Pro | 2009 |
Mineralocorticoid receptor blockers and chronic kidney disease.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Drug Therapy, Combination; Hu | 2009 |
[Chronic kidney disease and the aldosterone/mineralocorticoid receptor system].
Topics: Aldosterone; Animals; Chronic Disease; Eplerenone; Humans; Kidney Diseases; Metabolic Syndrome; Mine | 2010 |
Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
Topics: Aldosterone; Animals; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertensi | 2010 |
Aldosterone blockade in chronic kidney disease: can it improve outcome?
Topics: Aldosterone; Blood Pressure; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Hum | 2010 |
Endolymphatic hydrops: pathophysiology and experimental models.
Topics: Acute Disease; Aldosterone; Animals; Chronic Disease; Cyclic AMP; Disease Models, Animal; Endolymph; | 2010 |
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Cyclosporine; Diabetic Nephropathies; Humans; Kidney Diseases | 2011 |
Aldosterone-induced fibrosis in the kidney: questions and controversies.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Antihypertensive Agents; Blood Pressure; Child, | 2011 |
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure.
Topics: Aldosterone; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Mineralocorticoid Recept | 2011 |
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Topics: Aldosterone; Animals; Cardiovascular Diseases; Chronic Disease; Heart Failure; Hemodynamics; Humans; | 2012 |
Aldosterone in renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Clinical Trials as | 2003 |
[Aldosterone and its antagonists in heart failure].
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; | 2003 |
Aldosterone in chronic kidney and cardiac disease.
Topics: Aldosterone; Chronic Disease; Heart Diseases; Humans; Kidney Diseases | 2003 |
Aldosterone-induced vasculopathy.
Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Fibrosis; Heart Arrest; Heart Failure; Humans; | 2004 |
Eplerenone in the treatment of chronic heart failure.
Topics: Aldosterone; Chronic Disease; Clinical Trials as Topic; Eplerenone; Heart Failure; Humans; Mineraloc | 2004 |
[Diagnosis and treatment of primary hyperaldosteronism].
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Diagnosis, Differential; Hum | 2004 |
[Therapeutic application of ANP: past and future].
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Cardiopulmonary Bypass; Chronic Disease; Cyclic GMP | 2004 |
[Aldosterone antagonist therapy for chronic heart failure].
Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Diuretics; Eplerenone; Fibrosis; Heart Failure | 2005 |
The role of aldosterone blockers in the management of chronic heart failure.
Topics: Aldosterone; Animals; Chronic Disease; Heart Failure; Humans; Hypertrophy, Left Ventricular; Kidney; | 2005 |
[Chronic adrenocortical insufficiency(primary, secondary)].
Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Autoimmune Diseases; Chronic Disease; Hum | 2006 |
[Aldosterone antagonists: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Topics: Aldosterone; Chronic Disease; Contraindications; Eplerenone; Heart Failure; Humans; Mineralocorticoi | 2007 |
Aldosterone antagonism in chronic kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Humans; Kidney Diseases; Kidney Failure, Chronic; Mineralocor | 2006 |
[Disorders of water-salt metabolism in chronic diffuse liver diseases].
Topics: Aldosterone; Chronic Disease; Humans; Juxtaglomerular Apparatus; Liver Circulation; Liver Cirrhosis, | 1981 |
Aldosterone escape during ACE inhibitor therapy in chronic heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Chronic Disease; Drug T | 1995 |
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Heart Failure; Huma | 1996 |
Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Heart Failure; Humans; Miner | 1999 |
Aldosterone receptor blockade in the management of heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Heart Failure; Humans; Miner | 2002 |
[Humoral factors of circulatory disorders in chronic liver diseases].
Topics: Aldosterone; Bile Acids and Salts; Blood Protein Disorders; Blood Vessels; Cardiovascular Diseases; | 1975 |
Glucocorticoid and mineralocorticoid hormones in chronic liver diseases.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Chronic Disease; Circadian Rhythm; Cortiso | 1979 |
[Renovascular hypertension in pregnancy].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Female; Humans; Hypertension, Renal; K | 1969 |
[Physiopathology of renal hypertension].
Topics: Adult; Aldosterone; Angiotensin II; Animals; Chronic Disease; Dogs; Humans; Hypertension, Renal; Nep | 1970 |
The role of renal factors in the pathogenesis of experimental hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Cadmium; Cattle; Chronic Disease; Embolism; Glomerulonephritis | 1973 |
[Hepatogenous (secondary) aldosteronism (author's transl)].
Topics: Aldosterone; Angiotensin II; Chronic Disease; Esophageal and Gastric Varices; Hepatitis; Hepatitis A | 1974 |
[Disorders of sodium and potassium metabolism in liver diseases].
Topics: Acute Disease; Aldosterone; Biliary Tract Diseases; Body Fluids; Chronic Disease; Diuresis; Humans; | 1971 |
27 trials available for aldosterone and Chronic Illness
| Article | Year |
|---|---|
Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism.
Topics: Aged; Aldosterone; Biomarkers; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Heart Fai | 2015 |
Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction.
Topics: Aged; Aldosterone; Aminobutyrates; Angiotensin Receptor Antagonists; Area Under Curve; Biomarkers; B | 2016 |
Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure - Subanalysis of Waon-CHF Study.
Topics: Aldosterone; Case-Control Studies; Chronic Disease; Complementary Therapies; Heart Failure; Humans; | 2017 |
Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Chemokine CCL2; | 2008 |
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calciu | 2011 |
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Chroni | 2012 |
Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure | 2002 |
Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Cardiac Output, Low; Chronic Disease; Double-Blind Me | 2003 |
Inhibition of aldosterone and endothelin-1 by carperitide was attenuated with more than 1 week of infusion in patients with congestive heart failure.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Chronic Disease; Cy | 2005 |
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting E | 2006 |
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L- | 2007 |
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
Topics: Aged; Aldosterone; Amides; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhib | 2007 |
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Di | 1982 |
Renal haemodynamic changes, renal tubular function, sodium and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids.
Topics: Adult; Aldosterone; Amino Acids; Atrial Natriuretic Factor; Chronic Disease; Female; Glomerular Filt | 1994 |
Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris.
Topics: Administration, Cutaneous; Aged; Aldosterone; Angina Pectoris; Angiotensin-Converting Enzyme Inhibit | 1993 |
Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Gas Ana | 1996 |
Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure.
Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pr | 1997 |
Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Aorta, Thoracic; Chronic Disease; Compliance; | 1998 |
Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Antihypertensive Agents; Chronic Disease; Diuretics; Double-Bl | 1999 |
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Output; Cardiotonic Agents; Catecholamines; Ch | 2000 |
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Body Mass Index; Cachexia; | 2001 |
[Use of the aldosterone antagonist, canrenoate potassium for treating chronic circulatory insufficiency].
Topics: Adult; Aged; Aldosterone; Canrenoic Acid; Cardiovascular Diseases; Chronic Disease; Clinical Trials | 1979 |
Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity.
Topics: Administration, Cutaneous; Aged; Aldosterone; Angina Pectoris; Blood Pressure; Chronic Disease; Doub | 1992 |
A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic | 1989 |
Low-dose enalapril in severe chronic heart failure.
Topics: Aged; Aldosterone; Chronic Disease; Electrocardiography; Enalapril; Heart Failure; Heart Function Te | 1989 |
[Drug therapy of chronic inflammatory liver diseases].
Topics: Aldosterone; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Nandrolone; Predni | 1966 |
215 other studies available for aldosterone and Chronic Illness
| Article | Year |
|---|---|
Accelerated ageing and coronary microvascular dysfunction in chronic heart failure in Tgαq*44 mice.
Topics: Aging; Aldosterone; Angiotensins; Animals; Chronic Disease; Fibrosis; Heart Failure; Mice; Mice, Inb | 2023 |
Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents.
Topics: Acute Disease; Aldosterone; Animals; Blood Pressure; Cell Movement; Choroid; Choroid Diseases; Chron | 2019 |
Characteristics of hypertension in premature infants with and without chronic lung disease: a long-term multi-center study.
Topics: Aldosterone; Antihypertensive Agents; Chronic Disease; Female; Humans; Hypertension; Infant; Infant, | 2017 |
PECULIARITIES OF REMODELING OF HEART AND NEUROHUMORAL STATUS IN PATIENTS WITH CHRONIC HEART FAILURE AND CONCOMITANT RENAL DISEASE DEPENDING ON THE VALUE OF THE EJECTION FRACTION OF THE LEFT VENTRICLE.
Topics: Aldosterone; Chronic Disease; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocar | 2017 |
Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration.
Topics: Aldosterone; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Humans; Hyperglycemia; Male; M | 2018 |
Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Albuminuria; Aldosterone; Amiloride; Ankle Brachial Index; | 2019 |
Atorvastatin suppresses aldosterone-induced neonatal rat cardiac fibroblast proliferation by inhibiting ERK1/2 in the genomic pathway.
Topics: Aldosterone; Animals; Atorvastatin; Blotting, Western; Cell Cycle; Cell Proliferation; Cells, Cultur | 2013 |
Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide.
Topics: Aldosterone; Animals; Cardiotonic Agents; Chronic Disease; Collagen; Cytochrome P-450 CYP11B2; Disea | 2014 |
Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Topics: Adrenalectomy; Aldosterone; Animals; Chronic Disease; Cyclosporine; Cytochrome P-450 CYP11B2; Diseas | 2015 |
β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Aldosterone; Angiotensin | 2016 |
Possible mechanisms of cardiac contractile dysfunction and electrical changes in ammonium chloride induced chronic metabolic acidosis in Wistar rats.
Topics: Acidosis; Aldosterone; Ammonium Chloride; Animals; Chronic Disease; Echocardiography; Electrocardiog | 2016 |
Subclinical volume overload in stable outpatients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Asymptomatic Disease | 2016 |
Variability of biomarkers in patients with chronic heart failure and healthy controls.
Topics: Adult; Aged; Aldosterone; Biomarkers; Case-Control Studies; Chronic Disease; Creatinine; Female; Gal | 2017 |
Gestational Chronodisruption Impairs Circadian Physiology in Rat Male Offspring, Increasing the Risk of Chronic Disease.
Topics: Aldosterone; Animals; Blood Pressure; Body Temperature; Chronic Disease; Circadian Rhythm; CLOCK Pro | 2016 |
Aldosterone, hypertension, and cardiovascular disease: an endless story.
Topics: Aldosterone; Cardiovascular Diseases; Chronic Disease; Comorbidity; Disease Progression; Female; Hum | 2008 |
[Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenocorticotropic Hormone; Adult; Aldosterone; Case-C | 2008 |
Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.
Topics: Acetazolamide; Aldosterone; Animals; Calcium; Chronic Disease; Disease Models, Animal; Homeostasis; | 2008 |
Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Chronic Disease; Dexamethasone; Evoked Potentials, A | 2008 |
Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Catecholamines; Chronic Disease; Dependovirus; Di | 2009 |
Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.
Topics: Aged; Aldosterone; Blood Pressure Determination; Case-Control Studies; Catecholamines; Chronic Disea | 2009 |
Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.
Topics: Aldehydes; Aldosterone; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Dis | 2009 |
[Correlations between heart rate variability, renin activity and plasma aldosteron concentration in chronic glomerulonephritis with intact function of the kidneys].
Topics: Adult; Aldosterone; Autonomic Nervous System; Cardiovascular System; Chronic Disease; Glomerulonephr | 2009 |
[Renin-aldosterone system in patients with hypertensive form of chronic glomerulonephritis and preserved renal function].
Topics: Aldosterone; Blood Pressure; Chronic Disease; Glomerular Filtration Rate; Glomerulonephritis; Humans | 2009 |
Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
Topics: Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Chronic Disease; Diuretics; Follow-Up Studies; | 2009 |
Too much of a good thing: a woman with hypertension and hypokalemia.
Topics: Aldosterone; Chronic Disease; Dietary Supplements; Female; Glycyrrhiza; Glycyrrhizic Acid; Humans; H | 2009 |
[Adrenal insufficiency].
Topics: Acute Disease; Adrenal Insufficiency; Aldosterone; Chronic Disease; Hormone Replacement Therapy; Hum | 2009 |
Regulation of the nicotinic receptor alpha7 subunit by chronic stress and corticosteroids.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Aldosterone; alpha7 Nicotinic Acetylcholine Receptor; Andros | 2010 |
A physiologic-based approach to the evaluation of a patient with hyperkalemia.
Topics: Adult; Aldosterone; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Glomerular Fi | 2010 |
Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKD.
Topics: Acid-Base Equilibrium; Acidosis; Administration, Oral; Aldosterone; Animals; Bicarbonates; Chronic D | 2010 |
Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study.
Topics: Aldosterone; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Erythropoietin; Female; Follow- | 2010 |
Chronic potassium depletion increases adrenal progesterone production that is necessary for efficient renal retention of potassium.
Topics: Adrenal Glands; Aldosterone; Analysis of Variance; Animals; Cell Line; Chronic Disease; Corticostero | 2011 |
Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome.
Topics: Adolescent; Adult; Age of Onset; Aged; Aldosterone; Blood Pressure; Body Weight; Child, Preschool; C | 2011 |
Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.
Topics: Aldosterone; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Disease P | 2011 |
The influence of cardiac resynchronization therapy on selected inflammatory markers and aldosterone levels in patients with chronic heart failure.
Topics: Aged; Aldosterone; Biomarkers; C-Reactive Protein; Cardiac Resynchronization Therapy; Chronic Diseas | 2011 |
Neuroendocrine changes and natriuresis in response to social stress in rats.
Topics: Aldosterone; Analysis of Variance; Animals; Behavior, Animal; Catecholamines; Chronic Disease; Corti | 2012 |
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.
Topics: Aldosterone; Animals; Chronic Disease; Collagen Type I; Collagen Type IV; Cyclosporine; Fibronectins | 2003 |
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atri | 2003 |
Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Natriuretic Factor; Chronic Di | 2003 |
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arteries; Asp | 2003 |
[Spontaneous and induced variations of aldosteronuria and electrolyte balance in subjects with initial and chronic edemigenic cardiac failure].
Topics: Aldosterone; Chronic Disease; Heart Failure; Humans; Water-Electrolyte Balance | 1962 |
[PROCEDURE TO FOLLOW IN CHRONIC ADRENAL INSUFFICIENCY].
Topics: Addison Disease; Adrenal Insufficiency; Aldosterone; Chronic Disease; Cortisone; Desoxycorticosteron | 1964 |
Chronic hypokalaemia--how to establish a diagnosis?
Topics: Acid-Base Equilibrium; Adult; Aldosterone; Blood Pressure; Calcium; Chronic Disease; Creatinine; Dia | 2003 |
Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Caspase 2; Caspase 3; Caspase 8; Ca | 2004 |
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazol | 2005 |
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiac Pacing | 2005 |
Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia.
Topics: Aldosterone; Animals; Body Weight; Brain Chemistry; Central Nervous System; Chronic Disease; Cortico | 2005 |
Study of substance P, renin and aldosterone in chronic liver disease in Egyptian children.
Topics: Aldosterone; Case-Control Studies; Child; Chronic Disease; Egypt; Female; Humans; Liver Diseases; Ma | 2005 |
High prevalence of microalbuminuria in chronic heart failure patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Aldosterone; Angiotensin-Converti | 2005 |
Sex differences in postnatal growth and renal development in offspring of rabbit mothers with chronic secondary hypertension.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Chronic Disease; Creatinine; Female; Growth; Hype | 2007 |
Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
Topics: Aldosterone; Animals; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; | 2007 |
Regulation of CART mRNA by stress and corticosteroids in the hippocampus and amygdala.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenalectomy; Age Factors; Aldosterone; Amygdala; Androstan | 2007 |
Usefulness of the aldosterone synthase gene polymorphism C-344-T to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure.
Topics: Aldosterone; Alleles; Black or African American; Chronic Disease; Cytochrome P-450 CYP11B2; Echocard | 2007 |
Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, A | 2007 |
Effects of chronic hypoxia on electrogenic transport and transport-related oxygen consumption in rat distal colon.
Topics: Aldosterone; Analysis of Variance; Animals; Atmospheric Pressure; Chronic Disease; Colon; Electrophy | 2008 |
Aldosterone responses to angiotensin II, adrenocorticotropin, and potassium in chronic experimental diabetes mellitus in rats.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Chronic | 1984 |
Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Electrolytes; Enalapril; Female; | 1983 |
[Effect of an antidiuretic hormone on the aldosterone level in the blood plasma of rats with chronic water load and limited sodium intake].
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Chronic Disease; Corticosterone; Diet, Sodium-Res | 1984 |
[Renin-angiotensin-aldosterone system in diabetes mellitus].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Chronic Disease; Circadian Rhythm | 1981 |
Sodium homeostasis in chronic renal disease.
Topics: Aldosterone; Blood Proteins; Chronic Disease; Diet, Sodium-Restricted; Glomerular Filtration Rate; G | 1982 |
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Topics: Aged; Aldosterone; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Mi | 1983 |
The kinin system and other vasoactive substances in chronic liver disease.
Topics: Aldosterone; Chronic Disease; Diuresis; Humans; Kallikreins; Kinins; Liver Cirrhosis; Liver Diseases | 1983 |
Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure.
Topics: Administration, Oral; Aged; Aldosterone; Chronic Disease; Epinephrine; Female; Heart Failure; Hemody | 1983 |
[Renin-angiotensin-aldosterone system of elderly patients suffering from chronic ischemic heart disease].
Topics: Aged; Aldosterone; Chronic Disease; Coronary Disease; Humans; Middle Aged; Potassium; Renin; Renin-A | 1984 |
Plasma catecholamines and cardiovascular response in mild renal failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Catecholamines; Chronic Disease; Female; Glomerular Filtra | 1984 |
'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aged; Aldosterone; Chronic Disease; Humans; Hyperaldosteronism; Hy | 1984 |
[The renin-angiotensin-aldosterone system in chronic glomerulonephritis].
Topics: Adolescent; Adult; Aged; Aldosterone; Chronic Disease; Glomerular Filtration Rate; Glomerulonephriti | 1983 |
A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Topics: Aldosterone; Blood Pressure; Captopril; Catecholamines; Chronic Disease; Heart Failure; Hemodynamics | 1982 |
[Renin activity and aldosterone levels in the blood plasma in chronic ischemic heart disease in the elderly].
Topics: Adult; Aged; Aging; Aldosterone; Chronic Disease; Coronary Disease; Humans; Middle Aged; Renin; Reni | 1982 |
Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
Topics: Aldosterone; Chronic Disease; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Indome | 1982 |
Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease.
Topics: Adult; Aldosterone; Analysis of Variance; Angiotensin II; Chronic Disease; Female; Humans; Liver Cir | 1981 |
[Renal hemodynamics, the renin-angiotensin system and prostaglandins in the malignant and stable course of arterial hypertension].
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Chronic Disease; Female; Hemodynamics; Humans; Hyper | 1980 |
Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.
Topics: Adult; Aged; Aldosterone; Chronic Disease; Diet, Sodium-Restricted; Female; Humans; Hyperkalemia; Ki | 1980 |
[State of the central and renal hemodynamics, of electrolyte metabolism and of the renin-aldosterone system in chronic diseases of the small intestine].
Topics: Adolescent; Adult; Aldosterone; Animals; Chronic Disease; Electrolytes; Hemodynamics; Humans; Intest | 1980 |
[Hyporeninemic hypoaldosteronism syndrome caused by indomethacin].
Topics: Adolescent; Adult; Aldosterone; Chronic Disease; Female; Glomerulonephritis; Humans; Hyperkalemia; I | 1980 |
Decreased sensitivity to angiotensin II in chronic sustained hypernatremia.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Hypernatremia; Male; Middle Ag | 1980 |
The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Catecholamines; Chr | 1980 |
[Use of a radioimmunological study sequence for elucidating the role of vasopressor factors in the pathogenesis of hypertension].
Topics: Adult; Aldosterone; Chronic Disease; Coronary Disease; Humans; Hydrocortisone; Hypertension; Male; M | 1981 |
[Renal alterations in chronic respiratory insufficiency physiopathologic considerations (author's transl)].
Topics: Acidosis; Aldosterone; Angiotensin II; Chronic Disease; Humans; Hypercapnia; Hypoxia; Mineralocortic | 1981 |
Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Captopril; Chronic Disease; Creatinin | 1982 |
[Role of the angiotensin-aldosterone mechanism in the formation of Pulmonogenic arterial hypertension].
Topics: Aldosterone; Angiotensin I; Angiotensins; Chronic Disease; Humans; Hypertension; Hypertension, Pulmo | 1982 |
[Study of the hemodynamics of patients with symptomatic renal hypertension].
Topics: Adult; Aldosterone; Chronic Disease; Female; Glomerulonephritis; Hemodynamics; Humans; Hypertension, | 1982 |
Free water excretion due to suppressed vasopressin and stimulated aldosterone during sodium restriction in hypoaldosteronemic renal failure.
Topics: Adolescent; Adult; Aldosterone; Arginine Vasopressin; Body Water; Chronic Disease; Diet, Sodium-Rest | 1982 |
[Mineralocorticoid function of the adrenal cortex in chronic circulatory insufficiency].
Topics: Adolescent; Adrenal Cortex; Adult; Aged; Aldosterone; Chronic Disease; Female; Heart Failure; Humans | 1980 |
[Does long-term human recombinant erythropoietin (rHuEPO) influence secretion of hormones regulating volume and pressure of arterial blood?].
Topics: Adult; Aldosterone; Anemia; Arginine Vasopressin; Blood Pressure; Blood Volume; Chronic Disease; Ery | 1994 |
QT dispersion and sudden unexpected death in chronic heart failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Analysis of Variance; Atrial Natriuretic Factor; Biomarkers; C | 1994 |
The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Creatinine; Cyclos | 1993 |
Hormonal response to exercise in high altitude natives and COPD patients.
Topics: Adult; Aldosterone; Altitude; Atrial Natriuretic Factor; Chronic Disease; Epinephrine; Exercise; Exe | 1993 |
Acute effects of oral glucose loading on the renin-angiotensin-aldosterone system in patients with chronic renal disease.
Topics: Adult; Aldosterone; Blood Glucose; Chronic Disease; Creatinine; Glomerulonephritis; Glucose; Humans; | 1993 |
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Fact | 1995 |
Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Chronic Disease; Cyclic GMP; Diet, Sodium-Restricted; | 1997 |
Indomethacin attenuates the renal actions of atrial natriuretic factor in dogs with chronic heart failure.
Topics: Aldosterone; Animals; Arteriovenous Fistula; Atrial Natriuretic Factor; Chronic Disease; Creatinine; | 1997 |
Increased plasma vasopressin and atrial natriuretic peptide in chronic schizophrenic patients during abdominal surgery.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Case-Control Studies; Chronic Disease; Dopamine | 1998 |
The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Catecholamines; Chronic Disease; Di | 1998 |
Ultrastructure of the endolymphatic sac in two-phase endolymphatic hydrops in the guinea pig.
Topics: Aldosterone; Animals; Chronic Disease; Endolymphatic Hydrops; Endolymphatic Sac; Female; Guinea Pigs | 1999 |
Urea and osmotic excretion in rats exposed to chronic centrifugation.
Topics: Aldosterone; Animals; Blood Urea Nitrogen; Body Mass Index; Centrifugation; Chronic Disease; Disease | 1999 |
Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin.
Topics: Aldosterone; Animals; Blood Pressure; Cardiotonic Agents; Chronic Disease; Digitoxin; Digoxin; Hyper | 2000 |
Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients.
Topics: Acid-Base Equilibrium; Acidosis; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Chronic D | 2000 |
Chronic stress effects on the rat adrenal cortex.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Animals; Chronic Disease; Corticosterone; | 2000 |
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Gene De | 2001 |
Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Chronic Disease; Electric Countershock; Female; Humans; Male; Midd | 2001 |
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Chronic Diseas | 2002 |
Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; | 1983 |
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; | 2002 |
Potassium deficiency acidosis in the dog: effect of sodium and potassium balance on renal response to a chronic acid load.
Topics: Acidosis, Renal Tubular; Aldosterone; Ammonia; Ammonium Chloride; Animals; Bicarbonates; Calcium Chl | 1977 |
Renin aldosterone system and potassium levels in chronic lead intoxication.
Topics: Adult; Aged; Aldosterone; Chronic Disease; Creatinine; Edetic Acid; Female; Furosemide; Humans; Hype | 1979 |
[Comparative study of plasma levels of renin and aldosterone activity in essential arterial hypertension in relation to duration of the disease and the presence of complications].
Topics: Acute Disease; Adolescent; Adult; Aldosterone; Cardiomegaly; Chronic Disease; Female; Humans; Hypert | 1977 |
Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies.
Topics: Acidosis, Renal Tubular; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Chronic Disease; | 1976 |
[A case of chronic thyroiditis associated with hyposecretion of adrenocorticotrophic hormone (ACTH), growth hormone (GH), immunoreactive insulin (IRI) and aldosterone (author's transl)].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Chronic Disease; Female; Growth Hor | 1979 |
[Synacten test in the diagnosis of chronic adrenal insufficiency].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adul | 1979 |
[Disorder of the mineralocorticoid function of the adrenals in the acute period of myocardial infarct and the ways for its correction].
Topics: Acute Disease; Adrenal Gland Diseases; Adult; Aged; Aldosterone; Chronic Disease; Coronary Disease; | 1979 |
[Renin activity and adrenal functional indices in chronic circulatory insufficiency].
Topics: Adrenal Glands; Adult; Aldosterone; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Epin | 1979 |
Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.
Topics: Adult; Aldosterone; Ascites; Chronic Disease; Creatinine; Female; Humans; Ibuprofen; Indomethacin; K | 1979 |
[Conn's disease with an edematous form of chronic glomerulonephritis].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Chronic Disease; Edema; Female; Glomerulonephritis; Hum | 1979 |
[Renin activity and the aldosterone and cortisol content in the blood depending on the course of hypertension].
Topics: Adult; Aldosterone; Blood Pressure; Chronic Disease; Coronary Disease; Enzyme Activation; Humans; Hy | 1979 |
Autonomic blockade and the Valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study.
Topics: Adult; Aldosterone; Atropine; Blood Pressure; Blood Volume; Cardiac Output; Chronic Disease; Female; | 1977 |
Factors related to potassium transport in chronic stable renal disease in man.
Topics: Aldosterone; Chronic Disease; Humans; Kidney Diseases; Potassium; Renin | 1978 |
[State of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Chronic Disease; Coronary Disease; Humans; Renin | 1978 |
Chronic hypokalemic nephropathy: a clinical study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cathartics; Chlorides; Chronic Disease; Female; Humans; Hy | 1978 |
Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.
Topics: Acebutolol; Aldosterone; Animals; Chronic Disease; Clonidine; Corticosterone; Diet, Sodium-Restricte | 1977 |
Relationship between aldosterone and bradykinin.
Topics: Adrenal Insufficiency; Adult; Aldosterone; Angiotensin II; Bradykinin; Chronic Disease; Humans; Midd | 1977 |
Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease.
Topics: Aldosterone; Angiotensin II; Arginine Vasopressin; Carbon Dioxide; Chronic Disease; Humans; Kidney; | 1977 |
Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Liver Cirrhosis; Renin; Sarala | 1976 |
Letter: Hyporeninemic hypoaldosteronism in chronic renal disease.
Topics: Aldosterone; Chlorambucil; Chronic Disease; Female; Humans; Hypopituitarism; Nephritis; Prednisone; | 1975 |
Therapy and prognosis of hypertension in chronic nephritis.
Topics: Adult; Aldosterone; Angiotensin II; Blood Volume; Catecholamines; Chronic Disease; Creatinine; Extra | 1975 |
[Aldosterone excretion in patients with chronic nonspecific lung diseases].
Topics: Adrenal Cortex; Adult; Aldosterone; Chronic Disease; Circadian Rhythm; Female; Humans; Lung Diseases | 1975 |
[Renin-angiotensin-aldosterone system in hypertensive disease and arteriosclerotic myocardioslcerosis complicated by chronic circulatory insufficiency].
Topics: Aged; Aldosterone; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Female; Hum | 1975 |
[Renin-aldosterone behavior in hypertensive chronic glomerulonephritis].
Topics: Adult; Aldosterone; Chronic Disease; Glomerulonephritis; Humans; Hypertension, Renal; Middle Aged; R | 1975 |
[Hemodynamic changes, renin activity and aldosterone excretion in chronic circulatory insufficiency].
Topics: Aldosterone; Blood Circulation; Chronic Disease; Coronary Disease; Hemodynamics; Humans; Potassium; | 1975 |
Asymptomatic chronic hypomagnesemia and hypokalemia in a child: Cell membrane disease.
Topics: Aldosterone; Cell Membrane; Child; Chronic Disease; Humans; Hypokalemia; Kidney Function Tests; Magn | 1976 |
[Excretion of glucocorticoid hormones and aldosterone in pyelonephritis].
Topics: 17-Hydroxycorticosteroids; Aldosterone; Chronic Disease; Glucocorticoids; Humans; Pyelonephritis | 1976 |
[The correlation of humoral factors with the indices of the phasic structure of the left ventricular cardiac cycle in hypertension patients].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Chronic Disease; Combined Modality Therapy; Female; | 1992 |
Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exercise.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Chronic Disease; Exercise; Exercise Test; Femal | 1992 |
[The renin-angiotensin-aldosterone system and antidiuretic hormone in chronic circulatory failure in elderly subjects].
Topics: Aged; Aldosterone; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Renin; Renin-A | 1992 |
[The dynamics of the concentration of atrial natriuretic factor depending on changes in the arterial pressure level in patients with arterial hypertension].
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Captopril; Chronic Disease; Humans; Hydrochl | 1992 |
[The morphofunctional parallels in arterial hypertension in patients with chronic glomerulonephritis].
Topics: Aldosterone; Biopsy; Chronic Disease; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; | 1992 |
[The morphofunctional parallels in arterial hypertension in patients with chronic glomerulonephritis].
Topics: Adult; Aldosterone; Chronic Disease; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; | 1992 |
Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
Topics: Aldosterone; Analysis of Variance; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Biomark | 1992 |
A case of pseudoaldosteronism induced by glycyrrhizin.
Topics: Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Glycyrrhetinic Acid; Glycyrrh | 1992 |
[Functional state of the kidneys in patients with chronic diffuse bronchitis].
Topics: Adult; Aldosterone; Bronchitis; Chronic Disease; Humans; Immunoenzyme Techniques; Kidney; Middle Age | 1991 |
Aldosterone-secreting adenoma and dysautonomic failure: the challenging association of 2 extreme conditions.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Autonomic Nervous System Diseases; Chronic Disease; H | 1991 |
Disturbance in sodium regulating hormones in chronic obstructive uropathy.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Chronic Disease; Diuresis; Humans; Mid | 1991 |
Cyclical edema in a patient with hypothalamic disorders and chronic glomerulonephritis: arginine vasopressin-dependent atrial natriuretic hormone release.
Topics: Adult; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Body Weight; Chronic Disease; E | 1991 |
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Catheterization; Chronic Disease; Elect | 1991 |
Renin-dependency of glycyrrhizin-induced pseudoaldosteronism.
Topics: Adult; Alanine Transaminase; Aldosterone; Aspartate Aminotransferases; Blood Pressure; Catecholamine | 1991 |
[The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis].
Topics: Adult; Aldosterone; Blood Pressure; Chronic Disease; Female; Glomerulonephritis; Humans; Hypertensio | 1990 |
[Diurnal fluctuations of plasma renin activity and aldosterone level in patients with arterial hypertension].
Topics: Aldosterone; Blood Pressure; Chronic Disease; Circadian Rhythm; Humans; Hypertension; Hypertension, | 1990 |
ANF and postprandial control of sodium excretion in dogs with compensated heart failure.
Topics: Absorption; Aldosterone; Animals; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Cardiac | 1990 |
Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.
Topics: Aldosterone; Arginine Vasopressin; Atrial Fibrillation; Atrial Natriuretic Factor; Chronic Disease; | 1990 |
[Androstenedione, DHEA sulfate, cortisol, aldosterone and testosterone in bronchial asthma patients].
Topics: Adrenal Cortex Hormones; Adult; Aldosterone; Androstenedione; Asthma; Chronic Disease; Circadian Rhy | 1990 |
Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response.
Topics: Adult; Aldosterone; Blood Pressure; Chronic Disease; Diuretics; Female; Forearm; Heart Rate; Hemodyn | 1990 |
[The malignant hypertension syndrome: incontrovertible and questionable truths].
Topics: Aldosterone; Biopsy, Needle; Chronic Disease; Glomerulonephritis; Hemodynamics; Humans; Hydrocortiso | 1990 |
[The effect of hemosorption on the aldosterone and vasopressin content of the blood in patients with decompensated chronic cor pulmonale].
Topics: Adult; Aldosterone; Chronic Disease; Drug Interactions; Female; Heart Failure; Hemoperfusion; Hepari | 1990 |
Association of hypokalemia, aldosteronism, and renal cysts.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Chronic Disease; Female; Humans; Hyperaldoster | 1990 |
Changes in the renin-angiotensin-aldosterone system in rats of both sexes submitted to chronic hypobaric hypoxia.
Topics: Aldosterone; Altitude; Angiotensin II; Animals; Atmospheric Pressure; Blood Pressure; Chronic Diseas | 1987 |
[Atrial natriuretic factor in acute atrial hyperkinetic arrhythmia and chronic atrial fibrillo-flutter].
Topics: Acute Disease; Adult; Aged; Aldosterone; Atrial Fibrillation; Atrial Flutter; Atrial Natriuretic Fac | 1989 |
DOCA administration and atrial natriuretic factor in dogs with chronic heart failure.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Desoxycorticostero | 1989 |
[Hormonal changes in chronic diffuse diseases of the liver].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Chronic Disease; Female; Hepatitis, Chronic; Humans | 1989 |
[ADH (anti-diuretic hormone), aldosterone (PA) and renin activity (PRA) in patients with respiratory failure].
Topics: Acute Disease; Aged; Aldosterone; Chronic Disease; Female; Humans; Male; Middle Aged; Renin; Respira | 1989 |
Spontaneous neurohormonal fluctuation in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Chronic Disease; Circadian Rhythm; Electrolytes; Fem | 1988 |
Neurohumoral responses to chronic myocardial infarction in rats.
Topics: Aldosterone; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Chronic Disea | 1988 |
Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Dogs | 1989 |
Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Diuresis; Drug Eva | 1986 |
Sustained release verapamil in renal hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; | 1988 |
Atrial natriuretic peptide, angiotensin II and aldosterone in plasma in chronic glomerulonephritis during basal conditions and during exercise.
Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Exer | 1988 |
Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Chr | 1988 |
Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Topics: Aldosterone; Atrial Natriuretic Factor; Carcinoma, Hepatocellular; Chronic Disease; Female; Hepatiti | 1987 |
[The renin-angiotensin-aldosterone system in chronic diseases of the liver].
Topics: Adult; Aldosterone; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Middle Aged; Renin; Renin-A | 1988 |
Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Catecholamines; Chronic Disease; Drug A | 1988 |
Discrepancy between first-dose converting enzyme inhibition at rest and subsequent inhibition during exercise in chronic heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; | 1988 |
Suppression of plasma renin activity in a boy with chronic hyperkalemia.
Topics: Acidosis; Adolescent; Aldosterone; Body Height; Chronic Disease; Humans; Hyperkalemia; Male; Puberty | 1987 |
[Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke].
Topics: Aged; Aldosterone; Cerebrovascular Disorders; Chronic Disease; Humans; Hypertension; Middle Aged; Re | 1987 |
[Effect of captopril on plasma renin activity and blood aldosterone in patients with chronic pyelonephritis and urinary tract infection].
Topics: Adult; Aldosterone; Captopril; Chronic Disease; Enzyme Activation; Female; Humans; Middle Aged; Pyel | 1987 |
Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
Topics: Aldosterone; Ascites; Bilirubin; Cholinesterases; Chronic Disease; Depression, Chemical; Humans; Ind | 1986 |
Sodium and water balance in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Water; Captopril; Chronic Disease; Female; Heart Fail | 1986 |
[The renin-angiotensin-aldosterone system in children and adolescents with nephrogenic hypertension].
Topics: Adolescent; Aldosterone; Blood Pressure; Child; Chronic Disease; Fibromuscular Dysplasia; Humans; Hy | 1986 |
Effect of chronic hypokalaemia on renal concentrating ability and secretion of arginine vasopressin.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Bartter Syndrome; Chronic Disease; Female; | 1987 |
[Mineralocorticoid function of the adrenal cortex in men with gonorrhea].
Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; Adrenal Cortex; Aldosterone; Chronic Disease; | 1987 |
Mechanism of potassium depletion during chronic metabolic acidosis in the rat.
Topics: Acidosis; Adrenalectomy; Aldosterone; Ammonium Chloride; Animals; Chronic Disease; In Vitro Techniqu | 1987 |
Angiotensin II, aldosterone and arginine-vasopressin in exaggerated natriuresis of chronic glomerulonephritis.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Chronic Disease; Glomerulonephritis; Human | 1985 |
Is the antihypertensive effect of muzolimine due to volume depletion?
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Blood Volume; Chronic Disease; Creatini | 1985 |
[Central hemodynamic function and the metabolic electrolyte ratio of patients with hypertension and hereditary disposition].
Topics: Adolescent; Adult; Aged; Aging; Aldosterone; Catecholamines; Chronic Disease; Disease Susceptibility | 1985 |
Bed rest and increased diuretic treatment in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Bed Rest; Body Weight; Chronic Disease; Combined Modality Therapy; Diureti | 1985 |
[Hypotensive and diuretic effect of heparin in patients with glomerulonephritis].
Topics: Adolescent; Adult; Aldosterone; Antihypertensive Agents; Chronic Disease; Diuretics; Glomerulonephri | 1985 |
[Pilot study on the efficacy of high doses of aldosterone and spirolactone derivatives in the treatment of multiple sclerosis].
Topics: Adult; Aldosterone; Blood Pressure Determination; Body Weight; Chronic Disease; Electrocardiography; | 1972 |
ACTH stimulation of aldosterone secretion in normal subjects and in patients with chronic adrenocortical insufficiency.
Topics: Addison Disease; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Chron | 1967 |
Chronic laxative-induced hyperaldosteronism and hypokalemia simulating Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Blood Volume Determ | 1969 |
[Study on the renin-angiotensin-aldosterone system. Evaluation of the dynamics of renal renin and adrenal cortex aldosterone production in the chronic stage of Goldblatt's rats].
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Blood Pressure; Chromatography, Thin Layer; Ch | 1967 |
[Functional state of the renin-hypertension-aldosterone system in chronic circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Blood Circulation; Chronic Disease; Hemodynamics; Humans; Renin; Water- | 1972 |
[The state of adrenal cortical function in chronic alcoholism].
Topics: 11-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Alcoholism; Aldostero | 1973 |
[Symposium on pathophysiology of congestive heart failure. 1. Relationship of renin-angiotensin-aldosterone system to cardio-renal hemodynamics on chronic congestive heart failure (author's transl)].
Topics: Aldosterone; Angiotensin II; Chronic Disease; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Re | 1973 |
[Relationship angiotensine-aldosterone and respiratory function in chronic bronchial disease (author's transl)].
Topics: Aldosterone; Angiotensin II; Blood Volume; Body Height; Body Weight; Bronchopneumonia; Carbon Dioxid | 1972 |
Blood pressure regulation during chronic renal failure due to polycystic renal disease.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Hypertension, Renal; Kidney; K | 1974 |
Dynamic functions of angiotensin in hypertension: renal effects as the basic cause of chronic hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Dogs; Glomerular Filtration R | 1974 |
[Quadriplegia, severe hypokalemic alkalosis, tetany, arterial hypertension in relation to excessive licorice extract consumption in a chronic alcoholic].
Topics: Alcoholism; Aldosterone; Alkalosis; Chronic Disease; Diabetes Complications; Electrocardiography; Gl | 1972 |
[Aldosterone in glomerulonephritis].
Topics: Acute Disease; Aldosterone; Chronic Disease; Glomerulonephritis; Humans; Nephrotic Syndrome | 1972 |
[Significance of hyperaldosteronism in the pathogenesis of arterial hypertension in pheochromocytoma].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Biopsy; Catecholamines; Chromatography, Thi | 1973 |
[Effect of chronic stress on the production of aldosterone, 18-hydroxydeoxycorticosterone and corticosterone in rat adrenal glands].
Topics: Adaptation, Physiological; Adrenal Glands; Aldosterone; Animals; Chronic Disease; Corticosterone; De | 1973 |
[The secondary disease in internal medicine (antibacterial chemotherapy)].
Topics: Aldosterone; Anti-Infective Agents; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Huma | 1973 |
[Symposium on pathophysiology of congestive heart failure. 2. A clinical study of the "water-electrolyte regulation mechanism" in chronic congestive heart failure with emphasis on renin and catecholamine].
Topics: Adult; Aldosterone; Catecholamines; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Age | 1973 |
[Aldosteronism in liver diseases].
Topics: Acute Disease; Aldosterone; Chronic Disease; Humans; Hyperaldosteronism; Liver Diseases; Spironolact | 1974 |
Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis.
Topics: Adult; Aged; Aldosterone; Chronic Disease; Female; Humans; Hydronephrosis; Hypertension; Hypertensio | 1974 |
Resting and stimulated endocrine function in human subjects with cervical spinal cord transection.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Blood Glucose; Catecholamines; | 1971 |
Potassium-losing nephropathy of childhood.
Topics: Aldosterone; Biopsy; Child, Preschool; Chlorides; Chronic Disease; Diet, Sodium-Restricted; Humans | 1971 |
[Electrolytes of the blood, saliva and pancreatic secretion in chronic pancreatitis].
Topics: Adolescent; Adrenal Glands; Adult; Aldosterone; Chronic Disease; Female; Humans; Male; Middle Aged; | 1971 |
The effects of aldosterone and spirolactone on renal sodium and potassium excretion during mannitol diuresis.
Topics: Aldosterone; Alkalies; Animals; Chronic Disease; Diuresis; Dogs; Female; Humans; Injections, Intrave | 1968 |
A procedure for the measurement of urinary 17-hydroxycorticosteroids, aldosterone acid-labile conjugate, and free plasma cortisol in patients with chronic illness.
Topics: 17-Hydroxycorticosteroids; Acclimatization; Acetates; Acute Disease; Aldosterone; Anhydrides; Autono | 1969 |
[Mineral metabolism and the functional status of the adrenal cortex in chronic enterocolitis].
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adult; Aldosterone; Chronic Disease; Colitis; Enterocolit | 1969 |
The intercurrent hypertension of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Body Weight; Chronic Disease; Desoxyc | 1970 |
Selective aldosterone deficiency in chronic pyelonephritis.
Topics: Aged; Aldosterone; Blood Urea Nitrogen; Chronic Disease; Female; Fludrocortisone; Humans; Hyperkalem | 1970 |
[Secretion of aldosterone by the adrenal glands, its blood plasma concentration and urinary excretion of 3-oxo-aldosterone in patients with chronic circulatory insufficiency].
Topics: Adrenal Glands; Adult; Aldosterone; Cardiovascular Diseases; Chronic Disease; Humans; Methods; Potas | 1970 |
[On the hydro-natriuretic effect of progesterone in patients with chronic adrenal cortex insufficiency treated with mineralo-corticoids].
Topics: Addison Disease; Adrenal Insufficiency; Adult; Aldosterone; Chronic Disease; Diuresis; Humans; Male; | 1970 |
Studies on cardiac output to blood volume, and renal circulation in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Arteriosclerosis; Blood Pressure; Blood Volume; Cardiac Output; Chronic Di | 1968 |
[Renal hypertension and the juxtaglomerular apparatus].
Topics: Adolescent; Adult; Aged; Aldosterone; Chronic Disease; Female; Humans; Hydronephrosis; Hypertension, | 1968 |
[Significance of hypoplastic and pyelonephritic wrinkled kidneys in the development of arterial hypertension].
Topics: Adolescent; Adrenal Glands; Adult; Aldosterone; Aortography; Child; Chronic Disease; Congenital Abno | 1968 |
Secretion and turnover of aldosterone in various pathological states.
Topics: Adolescent; Adult; Aldosterone; Chronic Disease; Dehydration; Edema; Glomerulonephritis; Heart Failu | 1969 |